{"gene":"HMGB2","run_date":"2026-06-10T01:55:22","timeline":{"discoveries":[{"year":1993,"finding":"HMGB2 (HMG2) bends DNA extremely efficiently, forming circles as small as 66 bp, and can substitute for prokaryotic HU protein in promoting assembly of complex nucleoprotein invertasome structures, with HMG box domain B being sufficient for both bending and invertasome assembly.","method":"Ligase-mediated circularization assay, invertasome assembly assay, partial proteolytic digestion domain analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with domain-mapping by proteolysis, multiple orthogonal assays, replicated across different substrates","pmids":["8339930"],"is_preprint":false},{"year":1978,"finding":"HMG2 reduces the linking number of circular DNA when covalent closure occurs in its presence, indicating the protein unwinds the DNA double helix or induces supercoiling.","method":"Topological winding number assay with circular DNA and DNA ligase","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro biochemical assay, foundational finding replicated in subsequent studies","pmids":["628842"],"is_preprint":false},{"year":1979,"finding":"HMG2 unwinds the DNA double helix by local denaturation of base pairs; HMG2 shows higher affinity for single-stranded than double-stranded DNA in the presence of salt; the net unwinding angle is 26° per molecule of HMG2.","method":"Melting absorption technique, competition unwinding experiments measuring topological winding number","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro biochemical measurement, multiple quantitative methods","pmids":["226939"],"is_preprint":false},{"year":1995,"finding":"HMG2 activates transcription in a defined in vitro RNA polymerase II system by stabilizing an activated conformation of the TFIID-TFIIA-promoter complex; activation requires TFIIA and TAF-containing TFIID, and results in slower TFIIB dissociation from the preinitiation complex.","method":"Defined in vitro transcription reconstitution assay with purified factors, order-of-addition experiments, titration experiments","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 / Strong — fully reconstituted in vitro transcription system with purified components and multiple mechanistic tests","pmids":["7797075"],"is_preprint":false},{"year":1994,"finding":"HMG2 acts as a basal repressor of class II gene transcription by inhibiting steps after TBP-TFIIA-promoter complex assembly but before the fourth phosphodiester bond is formed; a TFIIH-associated factor counteracts this repression in an ATP/dATP-dependent manner.","method":"In vitro transcription assay with purified factors, order-of-addition experiments, antibody depletion of TFIIH, ATP analog inhibition","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted in vitro transcription with purified components, multiple mechanistic experiments including antibody depletion and nucleotide specificity tests","pmids":["8007973"],"is_preprint":false},{"year":1999,"finding":"The RAG1 homeodomain directly interacts with both HMG boxes of HMG2; this interaction facilitates RAG1/2 binding to recombination signal sequences (RSS) by promoting high-affinity binding to the nonamer motif, and HMG2 significantly enhances bending of the 23RSS.","method":"Protein-protein interaction assay, circular permutation DNA bending assay, electrophoretic mobility shift assay, in vivo V(D)J recombination assay in transfected cells","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct protein interaction demonstrated, multiple orthogonal methods including in vitro binding, bending assay, and in vivo recombination readout","pmids":["10490593"],"is_preprint":false},{"year":1999,"finding":"HMG2 is stably incorporated into the RAG1/RSS complex; it can increase the affinity of RAG1 for the RSS even in the absence of RAG2. Core RAG1 exists as a dimer both free in solution and as the minimal species bound to the RSS.","method":"Electrophoretic mobility shift assay (EMSA), recombinant protein expression, zinc analysis, cleavage activity assay","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct binding and functional assays with recombinant proteins, multiple orthogonal methods","pmids":["10390537"],"is_preprint":false},{"year":2002,"finding":"HMG2 is a component of the SET complex (270–420 kDa endoplasmic reticulum-associated complex containing SET, pp32, and APE); it coprecipitates with SET and colocalizes with SET at the endoplasmic reticulum in the cytoplasm. Cytoplasmic HMG2 mediates DNA binding and bending activity within the SET complex. HMG2 is a physiologically relevant granzyme A substrate; granzyme A cleaves HMG2 after Lys65 within HMG box A, destroying its DNA binding and bending functions.","method":"Co-immunoprecipitation, confocal microscopy colocalization, in vitro granzyme A cleavage assay, DNA binding/bending assays, single-stranded DNA nicking assay in isolated nuclei","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, colocalization, in vitro cleavage assay with functional readout, multiple orthogonal methods in single study","pmids":["11909973"],"is_preprint":false},{"year":2001,"finding":"HMGB2 physically interacts with p73α and p73β (pull-down assay); both HMG box domains A and B of HMGB1 interact with p73α; endogenous or ectopically expressed HMGB2 cell-specifically inhibits p73α/β- and p53-dependent transactivation from the Bax gene promoter in SAOS-2 cells, while stimulating it in H1299 cells.","method":"Pull-down assay, gel-shift assay (EMSA), transient transfection with luciferase reporter, antisense knockdown","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — pull-down, EMSA, and functional reporter assays in multiple cell lines with antisense knockdown, single lab but multiple orthogonal methods","pmids":["11748232"],"is_preprint":false},{"year":2001,"finding":"Hmgb2 knockout mice are viable but male Hmgb2-/- mice have reduced fertility associated with Sertoli and germ cell degeneration and immotile spermatozoa; in adult mice Hmgb2 is restricted to lymphoid organs and testes, though widely expressed during embryogenesis, indicating a specialized role in germ cell differentiation.","method":"Gene knockout (Hmgb2-/- mice), histological analysis, immunohistochemistry, fertility assay","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic knockout with specific cellular phenotype, replicated across multiple tissue analyses","pmids":["11262228"],"is_preprint":false},{"year":2003,"finding":"HMGB1 and HMGB2 are present in mitotic cells in two forms—free and chromatin-associated—that rapidly exchange; two sites encompassing HMG-box A and B are responsible for mitotic chromosome binding; previous immunofluorescence reports of dissociation from chromosomes during mitosis were artifacts of cell permeabilization or chemical fixation.","method":"Live-cell imaging with GFP/DsRed-tagged proteins, fluorescence recovery after photobleaching (FRAP), permeabilization controls","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — live imaging with domain mapping, rigorous controls showing fixation artifacts, direct functional consequence for subcellular localization","pmids":["12925773"],"is_preprint":false},{"year":1997,"finding":"Nuclear accumulation of HMG2 is mediated by basic regions interspaced with the HMG box DNA-binding sequence (a novel nuclear localization signal distinct from classic basic clusters); retention within the nucleus requires the acidic carboxyl terminus, as shown by interspecies heterokaryon assay.","method":"HMG2-β-galactosidase fusion protein expression in COS-7 cells, deletion analysis, interspecies heterokaryon assay","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — systematic deletion mapping of nuclear localization signal combined with heterokaryon retention assay","pmids":["9166769"],"is_preprint":false},{"year":1998,"finding":"HMG2 activates the nuclease activity of DFF40 (a caspase-3-activated apoptotic DNA fragmentation factor); bacterially expressed HMG2 enhances DFF40 nuclease activity in vitro, suggesting HMG proteins augment apoptotic DNA fragmentation through chromosomal structural changes.","method":"In vitro nuclease activity assay with purified recombinant proteins","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct in vitro functional assay with recombinant protein, single lab, single method","pmids":["9784391"],"is_preprint":false},{"year":1999,"finding":"HMG box B of HMG2 is the primary domain for DNA recognition and conformational changes (supercoiled DNA binding and DNA unwinding); box A requires the flanking basic linker region or box B to achieve full activity; Phe-102 in box B is predicted to intercalate into the base stack, whereas Ala-16 in box A is too small to intercalate.","method":"Gel retardation assay, DNA supercoiling assay, surface plasmon resonance (SPR), deletion/domain expression in E. coli, computer modeling","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro biochemical reconstitution with domain mutants and quantitative binding measurements (SPR), single lab but multiple orthogonal methods","pmids":["9888798"],"is_preprint":false},{"year":2005,"finding":"Isolated HMG box A from HMGB2 induces an average DNA bend angle of ~114° (at 50 mM Na+) via a flexible hinge mechanism at low concentrations; at higher concentrations, a cooperative filament binding mode is observed, distinct from the hinge mode.","method":"Single-molecule optical tweezers force-extension measurement of DNA","journal":"Biophysical journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct single-molecule biophysical measurement with quantitative parameters, characterizes two binding modes","pmids":["15833996"],"is_preprint":false},{"year":2009,"finding":"HMGB1 and HMGB2 upregulate cellular expression of topoisomerase IIα; HMGB1/2 knockdown significantly decreases topo IIα mRNA and protein levels; the mechanism involves HMGB1/2 modulating binding of transcription factor NF-Y to the topo IIα promoter, and this effect is dependent on pRb status (active in pRb-negative cells).","method":"siRNA knockdown, luciferase reporter assay (topo IIα promoter), western blot, RT-PCR, pRb overexpression rescue experiment","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — knockdown with mRNA and protein readouts, reporter assay, mechanistic link to NF-Y and pRb, single lab","pmids":["19223331"],"is_preprint":false},{"year":2009,"finding":"Age-related loss of HMGB2 in articular cartilage superficial zone is associated with reduced cellularity due to increased chondrocyte apoptosis; Hmgb2-/- mice show earlier onset and more severe osteoarthritis with increased cell death preceding glycosaminoglycan depletion.","method":"Hmgb2 knockout mice (Hmgb2-/-), histological analysis of cartilage, in vitro apoptosis assay of Hmgb2-/- chondrocytes","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with specific cellular phenotype (apoptosis) and in vitro validation, multiple readouts","pmids":["19139395"],"is_preprint":false},{"year":2009,"finding":"HMGB2 enhances binding of Lef-1 to its target sequence and potentiates transcriptional activation of the Lef-1-β-catenin complex; the HMG domain within HMGB2 is required for interaction with Lef-1; HMGB2 and Wnt/β-catenin pathway co-localize in the superficial zone, and conditional deletion of β-catenin in chondrocytes induces apoptosis.","method":"Co-immunoprecipitation, ChIP, transcription reporter assay, conditional knockout of β-catenin in chondrocytes, immunofluorescence","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct protein interaction (Co-IP), functional reporter assay, domain mapping, in vivo conditional knockout, multiple orthogonal methods","pmids":["19805379"],"is_preprint":false},{"year":2009,"finding":"Acetylated forms of HMGB1 and HMGB2 (in vivo acetylated) acquire the ability to bind to nucleosome core particles (not shown for non-acetylated forms); acetylation increases binding to linker DNA-containing nucleosomes and enhances co-remodeling activity with SWI/SNF and RSC; acetylated HMGB1/2 also enhance SWI/SNF binding to nucleosomes without affecting ATPase activity.","method":"Nucleosome binding assay, nucleosome mobilization/sliding assay with SWI/SNF and RSC, ATPase assay","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct biochemical assays with native acetylated protein and remodeling complexes, single lab, multiple assays","pmids":["19522541"],"is_preprint":false},{"year":2009,"finding":"HMGB2 directly binds to the GFI1B promoter in vivo and up-regulates its transactivation, most likely by enhancing the binding of Oct-1 and GATA-1 to the GFI1B promoter; knockdown of HMGB2 in hematopoietic progenitor cells decreases Gfi-1B expression and impairs erythroid differentiation.","method":"ChIP (chromatin immunoprecipitation), luciferase reporter assay, siRNA knockdown, erythroid differentiation assay","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP demonstrates in vivo promoter binding, reporter assay shows functional consequence, knockdown with differentiation phenotype, multiple orthogonal methods","pmids":["19965638"],"is_preprint":false},{"year":2011,"finding":"HMGB2 suppresses chondrogenic differentiation: lentiviral HMGB2 transduction of MSCs inhibits Col2a1 and Col10a1 expression, while Hmgb2-/- MSCs show enhanced Col10a1 and Runx2 expression; HMGB2 negatively regulates the stimulatory effect of Wnt/β-catenin signaling on the Runx2 proximal promoter.","method":"Lentiviral transduction, Hmgb2-/- MSC analysis, RT-PCR, luciferase reporter assay (Runx2 promoter), western blot","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — gain- and loss-of-function experiments with specific molecular readouts, multiple orthogonal methods, consistent in vitro and in vivo","pmids":["21890638"],"is_preprint":false},{"year":2012,"finding":"HMGB2 knockdown sensitizes colorectal cancer cells to ionizing radiation by increasing DNA damage and reducing DNA damage repair efficiency; p53 transcriptionally downregulates HMGB2 expression after radiation exposure, as shown by luciferase reporter assay (p53 reduces HMGB2 promoter activity) and by Nutlin-3/Tet-On p53 induction.","method":"shRNA knockdown, clonogenic survival assay, comet assay (DNA damage), luciferase reporter assay (HMGB2 promoter), Nutlin-3 treatment, Tet-On p53 induction system","journal":"Cancer biology & therapy","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple experimental approaches (functional radiosensitization, reporter assay, small-molecule p53 activation, inducible p53 expression), single lab","pmids":["23255232"],"is_preprint":false},{"year":2013,"finding":"Oct4 post-translational modifications (phosphorylation) promote Akt activation and interaction of Oct4 with Hmgb2 and the SET complex, which preserves H3K27me3 marks in daughter cells and maintains pluripotency gene expression in murine embryonic stem cells.","method":"Co-immunoprecipitation, western blot (H3K27me3 ChIP), phosphorylation mutant analysis, Akt inhibition","journal":"Stem cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP demonstrates physical interaction, PTM mutants show functional consequence, single lab","pmids":["23495099"],"is_preprint":false},{"year":2013,"finding":"Hmgb2-/- mice exhibit subventricular zone hyperproliferation with increased numbers of neural stem cells and increased newly born neurons in the olfactory bulb; loss of HMGB2 is associated with upregulation of p21 and NCAM and downregulation of Oct4 in the SVZ.","method":"Hmgb2-/- mouse analysis, BrdU/Ki67 immunohistochemistry, western blot, neurosphere assays","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockout with specific neurogenic phenotype, molecular marker analysis, single lab","pmids":["24391977"],"is_preprint":false},{"year":2014,"finding":"HMGB2 forms a complex with SRC-1 and estrogen receptor (ER) at promoter regions of target genes in tamoxifen-resistant breast cancer cells; HMGB2 ChIPseq reveals distinct binding patterns between endocrine-sensitive and -resistant contexts; the HMGB2/SRC-1/ER complex targets the RNA helicase DDX18, whose modulation directly affects growth of tamoxifen-resistant cells.","method":"Co-immunoprecipitation (SRC-1/HMGB2), ChIP-seq (HMGB2), gene expression analysis, DDX18 knockdown proliferation assay","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-seq genome-wide binding, co-IP for complex validation, functional knockdown of downstream target, multiple orthogonal methods","pmids":["25284587"],"is_preprint":false},{"year":2015,"finding":"HMGB2 directly binds to Lrp1-AS (a natural antisense lncRNA) and this interaction inhibits HMGB2's ability to enhance Srebp1a-dependent transcription of Lrp1; short oligonucleotides targeting Lrp1-AS inhibit the lncRNA-HMGB2 interaction and increase Lrp1 expression.","method":"RNA immunoprecipitation (RIP), in vitro binding assay, luciferase reporter assay (Lrp1 promoter), antisense oligonucleotide treatment","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct RNA-protein interaction demonstrated by RIP, functional reporter assay showing mechanistic consequence, oligonucleotide rescue experiment","pmids":["25937287"],"is_preprint":false},{"year":2016,"finding":"HMGB2 preferentially localizes to SASP gene loci during senescence; loss of HMGB2 allows spreading of repressive heterochromatin into SASP gene loci, causing SASP gene loci to be incorporated into SAHFs and blunting SASP gene expression; HMGB2 thus acts as a boundary factor preventing heterochromatin spreading.","method":"ChIP-seq (HMGB2, H3K9me2/3, H3K27me3), immunofluorescence, siRNA knockdown, gene expression analysis","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide ChIP-seq showing localization to SASP loci, loss-of-function with specific heterochromatin spreading phenotype, multiple epigenomic methods","pmids":["27799366"],"is_preprint":false},{"year":2016,"finding":"HMGB2 regulates myoblast proliferation and differentiation; knockdown of HMGB2 inhibits myoblast proliferation and stimulates differentiation by reducing Myf5 and cyclin A2 protein (not mRNA) levels; HMGB2 acts through transcriptional upregulation of IGF2BP2, an RNA-binding protein that enhances Myf5 translation and stabilizes cyclin A2 mRNA. In vivo HMGB2 depletion attenuates muscle regeneration and reduces satellite cell numbers.","method":"siRNA knockdown, lentiviral overexpression, western blot, RT-PCR, in vivo muscle injury model, ChIP, immunostaining","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 / Strong — gain- and loss-of-function in vitro and in vivo, pathway placement via IGF2BP2 rescue experiments, multiple orthogonal methods","pmids":["27672022"],"is_preprint":false},{"year":2018,"finding":"Nuclear depletion of HMGB2 occurs early upon senescence entry and is sufficient to cause senescence-associated CTCF clustering and loop reshuffling; ectopic HMGB2 expression rescues these effects; HMGB2 loss is thus a mechanistic driver of 3D genome reorganization at senescence entry.","method":"Hi-C (3D genome), single-cell and population transcriptomics, live imaging, in silico modeling, HMGB2 knockdown, HMGB2 overexpression rescue across three cell types","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — Hi-C genome reorganization data, knockdown and rescue in three independent cell types, multiple orthogonal methods","pmids":["29706538"],"is_preprint":false},{"year":2017,"finding":"HMGB2 promotes neointimal hyperplasia and VSMC proliferation/migration by inducing reactive oxygen species through increased p47phox phosphorylation; these effects are mediated through RAGE (receptor for advanced glycation end products) but not TLR4, as shown by knockdown/knockout experiments.","method":"Hmgb2-/- mouse femoral artery injury model, perivascular HMGB2 administration, siRNA knockdown of p47phox and RAGE/TLR4, ROS measurement, VSMC proliferation/migration assay","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo knockout and gain-of-function, receptor knockdown/knockout discriminating RAGE from TLR4, ROS mechanism, multiple orthogonal methods","pmids":["28183701"],"is_preprint":false},{"year":2009,"finding":"HMGB2 stabilizes p53 protein in HPV-positive HeLa cells by interfering with HPV E6/E6AP-mediated ubiquitination and proteasomal degradation of p53; HMGB2 overexpression in HeLa cells causes p53 accumulation, G1 cell cycle arrest, and decreased proliferation; this effect is specific to HPV-positive cells.","method":"siRNA knockdown, overexpression, western blot (p53 protein level), ubiquitination assay, FACS cell cycle analysis","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain- and loss-of-function with p53 protein stability readout, ubiquitination assay, specific cell-type context validated, single lab","pmids":["20036050"],"is_preprint":false},{"year":2019,"finding":"HMGB2 is required for the differentiation and maintenance of stem-like progenitor exhausted CD8+ T cells (Tpex) during chronic viral infection and in tumors through epigenetic and transcriptional programming; Hmgb2-/- CD8+ T cells cannot sustain Tpex differentiation and long-term survival during persistent antigen despite expressing TCF-1 and TOX.","method":"Hmgb2-/- mice, chronic LCMV infection model, tumor models, flow cytometry, ATAC-seq, RNA-seq, single-cell analysis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout in multiple in vivo models (chronic infection and tumor), epigenomic (ATAC-seq) and transcriptomic evidence of programming role","pmids":["37704621"],"is_preprint":false},{"year":2019,"finding":"HMGB2 is a transcriptional suppressor of latexin; HMGB2 knockdown increases latexin expression and decreases hematopoietic stem cell (HSC) number and regeneration capacity in vivo; concomitant latexin blockade rescues HSC numbers; a functional SNP (rs31528793) in the latexin promoter differentially binds HMGB2 and affects promoter activity.","method":"DNA pull-down with mass spectrometry (identification), HMGB2 knockdown in mice, in vivo HSC number and regeneration assays, luciferase reporter assay (latexin promoter with SNP variants), western blot/RT-PCR","journal":"Haematologica","confidence":"High","confidence_rationale":"Tier 2 / Strong — protein identified by DNA pull-down/MS, in vivo knockdown with HSC phenotype, mechanistic rescue, SNP-promoter reporter assay, multiple orthogonal methods","pmids":["31171637"],"is_preprint":false},{"year":2019,"finding":"HMGB2 is a negative regulator of telomerase activity in human embryonic stem cells and neuroectodermal cells; HMGB2 knockdown stimulates telomerase activity potentially through activation of PI3K/AKT/GSK3β/β-catenin pathways and augmented TERT transcription, while HMGB1 has the opposite (enhancing) effect on telomerase.","method":"Inducible shRNA knockdown in hESCs and neuroectodermal cells, telomerase activity assay (TRAP), RT-PCR for TERT/TERC, signaling pathway inhibition","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — inducible knockdown system with telomerase activity assay and pathway analysis, single lab, multiple cell types","pmids":["31661640"],"is_preprint":false},{"year":2021,"finding":"HMGB2 mediates adipogenesis by binding to the C/EBPβ promoter at the sequence 'GGGTCTCAC' specifically during mitotic clonal expansion (MCE) stage, enhancing C/EBPβ expression; exogenous C/EBPβ rescues adipogenic impairment caused by HMGB2 depletion; Hmgb2-/- mice have decreased adipose tissue mass.","method":"Hmgb2-/- mice, ChIP (HMGB2 binding to C/EBPβ promoter), lentiviral overexpression/knockdown, C/EBPβ rescue experiment, qPCR, western blot, in vivo adipose tissue analysis","journal":"Cell death & disease","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct promoter occupancy by ChIP, rescue experiment, in vivo knockout phenotype, multiple orthogonal methods","pmids":["34215724"],"is_preprint":false},{"year":2024,"finding":"NAT10-mediated N4-acetylcytidine (ac4C) modification within the coding sequence (CDS) of HMGB2 mRNA enhances HMGB2 translation by facilitating binding of eukaryotic elongation factor 2 (eEF2) to the ac4C sites; this NAT10-ac4C/eEF2-HMGB2 axis promotes HCC proliferation and metastasis.","method":"acRIP-seq, RNA-seq, ribosome profiling, RNA immunoprecipitation, RNA pull-down, mass spectrometry, site-specific mutation, CETSA/DARTS drug binding assay, in vitro and in vivo HCC models","journal":"Cancer communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — epitranscriptomic sequencing (acRIP-seq) + ribosome profiling + RNA pull-down + site-specific mutation demonstrating mechanism, single lab but multiple orthogonal methods including functional rescue","pmids":["39030964"],"is_preprint":false},{"year":2024,"finding":"HMGB2 secretion from the cell nucleus into the extracellular milieu is required for oxaliplatin-induced calreticulin (CRT) translocation to the plasma membrane (a required step for immunogenic cell death); nuclear export of HMGB2 is controlled by XPO1 (CRM1); XPO1 inhibition causes nuclear HMGB2 accumulation and inhibits CRT translocation and ferroptosis; exogenous cell-targeted HMGB2 (CT-HMGB2) is three orders of magnitude more potent than oxaliplatin at inducing CRT translocation.","method":"XPO1 inhibition (selinexor), nuclear fractionation, confocal microscopy (CRT translocation), ferroptosis assay, exogenous CT-HMGB2 protein treatment, flow cytometry","journal":"Communications biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — pharmacological inhibition of nuclear export, exogenous protein rescue experiment, direct mechanistic link between HMGB2 secretion and CRT translocation, multiple cell lines and orthogonal readouts","pmids":["39354146"],"is_preprint":false},{"year":2022,"finding":"Spatiotemporal expression of HMGB2 regulates hepatocyte proliferation and cell size during liver regeneration; Hmgb2-/- mice show significantly delayed hepatocyte proliferation with decreased cyclin D1 and cyclin B1 mRNA, and larger hepatocytes after partial hepatectomy, indicating hepatocyte hypertrophy compensates for reduced proliferation.","method":"Hmgb2-/- mice, 70% partial hepatectomy model, immunohistochemistry (Ki67, PCNA), flow cytometry, qPCR (cyclin D1/B1), siRNA knockdown in vitro","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with in vivo regeneration model, specific molecular readouts (cyclins), in vitro validation with siRNA","pmids":["35831365"],"is_preprint":false},{"year":2018,"finding":"Loss of HMGB2 in cardiomyocytes causes AKT inactivation and decreased SERCA2a activity; Hmgb2-/- mice show baseline cardiac dysfunction and worsened cardiac dysfunction after TAC (pressure overload), demonstrating HMGB2 has a cardioprotective role by maintaining AKT signaling and calcium pump activity.","method":"Hmgb2-/- mice, TAC surgery, echocardiography, western blot (AKT phosphorylation, SERCA2a), cardiac function measurements","journal":"Circulation journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockout with in vivo cardiac phenotype and molecular mechanism (AKT, SERCA2a), single lab","pmids":["30487376"],"is_preprint":false},{"year":2018,"finding":"HMGB2 overexpression promotes ischemia/reperfusion-induced apoptosis through activating the JNK1/2-NF-κBp65 signaling pathway in AC16 cardiomyocytes; HMGB2 silencing inhibits I/R-induced JNK1/2 and NF-κBp65 activation; JNK1/2 inhibitor (SP600125) and NF-κB inhibitor (PDTC) reverse HMGB2 overexpression-induced injury.","method":"HMGB2 overexpression and shRNA knockdown, SP600125/PDTC pharmacological inhibition, western blot (JNK1/2, NF-κBp65, Bax/Bcl-2, caspase-3), CCK-8, flow cytometry, TUNEL","journal":"Biomedicine & pharmacotherapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain- and loss-of-function with pathway inhibitor validation, single lab, multiple molecular readouts","pmids":["30119172"],"is_preprint":false},{"year":2023,"finding":"Post-translational modifications (PTMs) of HMGB2 are located predominantly in the B-domain and within the linker region (in contrast to HMGB1 where PTMs are in the A-domain and linker), as determined by MALDI mass spectrometry; despite high sequence homology, HMGB1 and HMGB2 have slightly different secondary structures as measured by CD spectroscopy.","method":"MALDI mass spectrometry (PTM mapping), UV circular dichroism spectroscopy","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — direct structural and PTM characterization by two methods but limited functional validation of PTM consequences","pmids":["36834988"],"is_preprint":false},{"year":2023,"finding":"HMGB2 is required for hepatic stellate cell (HSC) activation and liver fibrosis; Hmgb2-/- mice or HMGB2-inhibitor (inflachromene)-treated mice show impaired HSC transdifferentiation (reduced α-SMA) and slowed CCl4-induced fibrosis; AAV8-mediated HMGB2 overexpression enhances fibrosis; RNA-seq in Hmgb2-/- mice identifies top activated genes in integrin signaling, inflammation, cell cycle, and extracellular matrix pathways.","method":"Hmgb2-/- mice, AAV8-Hmgb2 overexpression, CCl4 fibrosis model, primary HSC isolation and transdifferentiation assay, small molecule inhibitor (inflachromene), lipo-shHMGB2, RNA-seq","journal":"Hepatology communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout and gain-of-function in vivo, primary cell isolation, pharmacological inhibition, RNA-seq pathway analysis, multiple orthogonal approaches","pmids":["37930124"],"is_preprint":false},{"year":2016,"finding":"HMGB2 promotes myocardial ischemic injury in rats by enhancing reactive oxygen species (ROS) production via RAGE signaling, thereby aggravating cardiomyocyte apoptosis, inflammation, and autophagosome clearance impairment; RAGE knockdown attenuates HMGB2-induced effects; TLR4 is not involved.","method":"Intramyocardial HMGB2 protein injection in MI rats, NADPH oxidase inhibitor (apocynin) co-treatment, RAGE knockdown (siRNA), ROS measurement, echocardiography, histopathology, western blot","journal":"American journal of physiology. Heart and circulatory physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct protein injection in vivo, receptor knockdown distinguishing RAGE from TLR4, ROS mechanism, single lab","pmids":["28011583"],"is_preprint":false},{"year":2018,"finding":"HMGB2 knockdown in colorectal cancer cells reduces VSMC-like migration and invasion by stabilizing HMGB2 in the cytoplasm; lnc-CRCMSL physically binds HMGB2 and retains it in the cytoplasm, preventing nuclear entry; nuclear HMGB2 triggers EMT by interacting with OCT4; leptomycin B (nuclear export inhibitor) counteracts lnc-CRCMSL-mediated suppression by accumulating nuclear HMGB2.","method":"RNA pull-down assay (lnc-CRCMSL/HMGB2 interaction), subcellular fractionation, immunofluorescence, leptomycin B treatment, co-IP (HMGB2/OCT4), knockdown/overexpression, in vivo tumor model","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct RNA-protein interaction by pull-down, HMGB2/OCT4 co-IP, nuclear export inhibitor experiment, subcellular localization with functional consequence","pmids":["30575817"],"is_preprint":false},{"year":2020,"finding":"miR-127-5p inhibits granulosa cell (GC) proliferation and impairs DNA damage repair capacity by targeting HMGB2; miR-127-5p upregulation in GCs from premature ovarian insufficiency patients reduces HMGB2 protein; in vivo, miR-127-5p attenuates DNA repair via HMGB2 in mouse ovary.","method":"miRNA mimic/inhibitor transfection, luciferase reporter assay (HMGB2 3'UTR), western blot, DNA damage repair assay, orthotopic mouse model, flow cytometry","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct target validation by 3'UTR reporter assay, in vitro and in vivo functional assays, single lab","pmids":["32391592"],"is_preprint":false},{"year":1995,"finding":"HMG2 mRNA level peaks at G2 phase of the cell cycle in rat fibroblasts; expression of antisense HMG2 RNA in COS-1 cells represses cell cycle progression at G1/S, resulting in decreased cell growth, indicating HMG2 expression is required for cell proliferation.","method":"Northern blot (cell cycle staging), antisense RNA expression (cell cycle analysis)","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — antisense loss-of-function with specific cell cycle arrest phenotype, cell cycle expression profiling, single lab","pmids":["7763232"],"is_preprint":false}],"current_model":"HMGB2 is a multifunctional chromatin-associated architectural protein that bends and unwinds DNA through its two HMG box domains (box B being the primary DNA recognition/bending domain), activates RNA Pol II transcription by stabilizing the TFIID-TFIIA-promoter complex, and also represses basal transcription until counteracted by TFIIH-associated ATPase activity; it participates in diverse gene-regulatory complexes (with RAG1/2 for V(D)J recombination, Lef-1/β-catenin for Wnt signaling, p53/p73, ER/SRC-1, Oct4/SET, and GFI1B-promoter-associated factors); its nuclear localization is determined by HMG box flanking basic regions with retention requiring the acidic C-terminus; acetylation enhances its nucleosome binding and chromatin-remodeling co-activity; its nuclear depletion upon senescence entry drives CTCF clustering and 3D genome reorganization that primes the SASP, while its preferential localization to SASP gene loci prevents heterochromatin spreading into these regions; extracellular HMGB2 (secreted via XPO1-dependent nuclear export) induces calreticulin translocation for immunogenic cell death and activates RAGE-mediated ROS signaling; loss of HMGB2 in vivo causes defects in spermatogenesis, cartilage homeostasis, erythroid differentiation, muscle regeneration, neural stem cell proliferation, hematopoietic stem cell maintenance, adipogenesis, hepatocyte proliferation, cardiac function (via AKT/SERCA2a), and T cell exhaustion differentiation."},"narrative":{"mechanistic_narrative":"HMGB2 is a sequence-nonspecific architectural chromatin protein that uses its two HMG box domains to bend, unwind, and structurally remodel DNA, thereby acting as a versatile facilitator of nucleoprotein complex assembly and gene regulation [PMID:8339930, PMID:226939, PMID:9888798]. It bends DNA extremely efficiently — forming circles as small as 66 bp and substituting for prokaryotic HU in invertasome assembly — and reduces DNA linking number by local denaturation of base pairs, with box B serving as the primary DNA-recognition and bending domain (Phe-102 intercalating into the base stack) and box A acting through a flexible hinge mechanism [PMID:8339930, PMID:628842, PMID:226939, PMID:9888798, PMID:15833996]. Through these activities HMGB2 modulates transcription in opposing directions: in reconstituted RNA Pol II systems it activates transcription by stabilizing the TFIID-TFIIA-promoter complex and slowing TFIIB dissociation, yet also acts as a basal repressor of class II genes that is relieved by an ATP-dependent TFIIH-associated activity [PMID:7797075, PMID:8007973]. As an architectural co-factor it is recruited into diverse regulatory complexes — the RAG1/2 recombinase machinery where it enhances binding and bending of recombination signal sequences [PMID:10490593, PMID:10390537], Lef-1/β-catenin Wnt complexes [PMID:19805379], the SET complex at the ER [PMID:11909973], and ER/SRC-1 complexes in tamoxifen-resistant breast cancer [PMID:25284587] — and it directly occupies and regulates specific promoters including GFI1B, C/EBPβ, and latexin to control erythroid differentiation, adipogenesis, and hematopoietic stem cell maintenance [PMID:19965638, PMID:31171637, PMID:34215724]. Its activity is tuned by acetylation, which confers nucleosome-core-particle binding and enhances co-remodeling with SWI/SNF and RSC [PMID:19522541], and its nucleocytoplasmic distribution is governed by an HMG-box-flanking NLS, acidic C-terminal retention, and lncRNA binding, with granzyme A cleavage after Lys65 destroying its DNA functions [PMID:11909973, PMID:9166769, PMID:30575817]. In senescence HMGB2 is depleted from the nucleus, an event sufficient to drive CTCF clustering and 3D genome reorganization while its preferential occupancy of SASP loci shields them from heterochromatin spreading [PMID:27799366, PMID:29706538]. Secreted HMGB2, exported via XPO1, signals extracellularly through RAGE-mediated ROS to drive vascular and myocardial injury and induces calreticulin translocation for immunogenic cell death [PMID:28183701, PMID:39354146, PMID:28011583]. Across genetic knockouts, HMGB2 is required for spermatogenesis, cartilage homeostasis, neural stem cell control, muscle regeneration, hepatocyte proliferation, adipogenesis, hematopoietic stem cell maintenance, and exhausted-progenitor T cell differentiation [PMID:11262228, PMID:19139395, PMID:24391977, PMID:27672022, PMID:37704621, PMID:34215724, PMID:35831365].","teleology":[{"year":1979,"claim":"Established the foundational biochemical activity of HMGB2 on DNA structure, defining it as a DNA-distorting protein rather than a sequence-specific factor.","evidence":"Topological winding number assays and melting absorption measurements with circular DNA","pmids":["628842","226939"],"confidence":"High","gaps":["Did not address sequence preference or in vivo relevance","Quantitative unwinding angle measured in vitro only"]},{"year":1995,"claim":"Demonstrated HMGB2 bends DNA extremely efficiently and identified box B as sufficient for bending and complex nucleoprotein assembly, framing HMGB2 as an architectural facilitator.","evidence":"Ligase-mediated circularization, invertasome assembly, and partial proteolysis domain mapping","pmids":["8339930"],"confidence":"High","gaps":["Box A contribution not fully resolved","Physiological nucleoprotein targets not identified"]},{"year":1999,"claim":"Refined the division of labor between the HMG boxes, showing box B is the primary DNA-recognition/bending domain with an intercalating residue while box A acts via a flexible hinge.","evidence":"Gel retardation, SPR, supercoiling assays with domain mutants, single-molecule optical tweezers, computer modeling","pmids":["9888798","15833996"],"confidence":"High","gaps":["Cooperative filament binding mode mechanism incompletely defined","In vivo consequences of distinct binding modes unclear"]},{"year":1995,"claim":"Linked HMGB2's biochemical DNA activity to transcriptional control, showing it both activates Pol II transcription by stabilizing TFIID-TFIIA and represses basal transcription until relieved by TFIIH ATPase activity.","evidence":"Defined reconstituted in vitro Pol II transcription with purified factors, order-of-addition, antibody depletion, nucleotide-analog tests","pmids":["7797075","8007973"],"confidence":"High","gaps":["The TFIIH-associated counteracting factor not molecularly identified","Promoter context determining activation vs repression not defined"]},{"year":1999,"claim":"Placed HMGB2 in the V(D)J recombination machinery, showing it is incorporated into RAG1/RSS complexes and enhances RAG binding and 23RSS bending.","evidence":"Protein-protein interaction, EMSA, circular permutation bending, in vivo recombination assays with recombinant proteins","pmids":["10490593","10390537"],"confidence":"High","gaps":["Stoichiometry within the cleavage complex not resolved","Relative roles of HMGB1 vs HMGB2 in vivo not distinguished"]},{"year":1997,"claim":"Defined how HMGB2 subcellular localization is controlled, identifying a novel HMG-box-interspaced NLS and an acidic C-terminal nuclear retention requirement.","evidence":"Fusion-protein deletion mapping in COS-7 cells and interspecies heterokaryon retention assay","pmids":["9166769"],"confidence":"High","gaps":["Trans-acting import/retention factors not identified","Regulation of shuttling by signals not addressed"]},{"year":2002,"claim":"Revealed a cytoplasmic, ER-associated pool of HMGB2 within the SET complex and identified it as a granzyme A substrate, connecting its DNA activity to cytotoxic cell death.","evidence":"Reciprocal co-IP, confocal colocalization, in vitro granzyme A cleavage with functional DNA-binding readouts","pmids":["11909973"],"confidence":"High","gaps":["Functional role of cytoplasmic HMGB2 beyond cleavage substrate unclear","Regulation of nuclear vs cytoplasmic partitioning of the SET complex not defined"]},{"year":2003,"claim":"Clarified that HMGB2 remains dynamically associated with mitotic chromosomes, correcting prior fixation artifacts and mapping two binding sites to boxes A and B.","evidence":"Live-cell imaging of tagged proteins, FRAP, permeabilization controls","pmids":["12925773"],"confidence":"High","gaps":["Functional consequence of mitotic chromosome binding not established","Exchange kinetics not linked to a regulatory output"]},{"year":2009,"claim":"Established HMGB2 as a partner in multiple transcription-factor complexes governing differentiation, including Lef-1/β-catenin Wnt signaling and direct GFI1B promoter regulation for erythroid differentiation, with acetylation enabling nucleosome binding and chromatin co-remodeling.","evidence":"Co-IP, ChIP, reporter assays, conditional β-catenin knockout, nucleosome mobilization with SWI/SNF and RSC, siRNA differentiation assays","pmids":["19805379","19965638","19522541"],"confidence":"High","gaps":["Acetylation effects shown for native protein but site-specific causality limited","Generality of complex recruitment across loci not fully mapped"]},{"year":2001,"claim":"Connected HMGB2 to the p53/p73 tumor-suppressor axis, showing it binds p73 and contextually modulates p53/p73-dependent transactivation, and later that it stabilizes p53 by blocking HPV E6-mediated degradation.","evidence":"Pull-down, EMSA, luciferase reporters, ubiquitination assay, cell cycle FACS across multiple cell lines","pmids":["11748232","20036050"],"confidence":"High","gaps":["Cell-type-dependent opposite effects mechanistically unexplained","p53-stabilization restricted to HPV-positive context"]},{"year":2009,"claim":"Defined in vivo physiological requirements for HMGB2 through cartilage knockout studies, linking its loss to chondrocyte apoptosis and accelerated osteoarthritis, and showing it suppresses chondrogenic differentiation via Wnt/Runx2.","evidence":"Hmgb2-/- mice, histology, in vitro apoptosis and reporter assays, MSC gain/loss-of-function","pmids":["19139395","21890638"],"confidence":"High","gaps":["Direct chromatin targets in chondrocytes not enumerated","Mechanism coupling DNA binding to apoptosis protection unclear"]},{"year":2016,"claim":"Established HMGB2 as a master regulator of senescence-associated genome architecture, acting both as a driver of CTCF clustering/3D reorganization and as a boundary factor protecting SASP loci from heterochromatin spreading.","evidence":"ChIP-seq for HMGB2 and histone marks, Hi-C, knockdown and rescue across multiple cell types, immunofluorescence","pmids":["27799366","29706538"],"confidence":"High","gaps":["Mechanism by which HMGB2 marks SASP boundaries molecularly undefined","Trigger for nuclear depletion at senescence entry unknown"]},{"year":2016,"claim":"Showed HMGB2 controls myogenic and other tissue regeneration programs through transcriptional regulation of downstream effectors such as IGF2BP2, coupling chromatin function to satellite/progenitor cell behavior.","evidence":"siRNA/overexpression, ChIP, IGF2BP2 rescue, in vivo muscle injury model","pmids":["27672022"],"confidence":"High","gaps":["Direct vs indirect promoter occupancy at IGF2BP2 partially resolved","Generalizability across regenerating tissues not tested in one model"]},{"year":2017,"claim":"Defined an extracellular signaling role for HMGB2, acting through RAGE (not TLR4) to drive ROS production and tissue injury in vascular and myocardial contexts.","evidence":"Hmgb2-/- injury models, perivascular/intramyocardial protein administration, RAGE/TLR4 knockdown, ROS and NADPH oxidase assays","pmids":["28183701","28011583"],"confidence":"High","gaps":["Secretion mechanism in these contexts not defined","Downstream RAGE effector pathway partially characterized"]},{"year":2018,"claim":"Demonstrated that HMGB2 nucleocytoplasmic partitioning is regulated by lncRNAs and XPO1-dependent export, with localization dictating function from EMT (nuclear/OCT4) to immunogenic cell death (secreted/calreticulin).","evidence":"RNA pull-down, subcellular fractionation, leptomycin B/selinexor export inhibition, co-IP, CRT translocation and ferroptosis assays, exogenous CT-HMGB2 protein","pmids":["30575817","39354146","25937287"],"confidence":"High","gaps":["Signals triggering XPO1-dependent secretion not identified","Relationship between lncRNA sequestration and active export not integrated"]},{"year":2024,"claim":"Revealed an epitranscriptomic layer controlling HMGB2 abundance, where NAT10-mediated ac4C modification of HMGB2 mRNA enhances its translation via eEF2 binding to promote tumor proliferation.","evidence":"acRIP-seq, ribosome profiling, RNA pull-back/MS, site-specific mutation, in vitro and in vivo HCC models","pmids":["39030964"],"confidence":"High","gaps":["Whether ac4C regulation operates outside HCC unknown","Quantitative contribution of translation control vs transcription not separated"]},{"year":null,"claim":"How the same architectural protein achieves opposing transcriptional outcomes and partitions among nuclear chromatin, cytoplasmic complexes, and secreted signaling pools in a context-specific manner remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No unifying model linking DNA-bending activity to selective gene-regulatory outcomes","Upstream signals dictating subcellular partitioning and secretion not defined","Functional distinction between HMGB1 and HMGB2 at shared loci incompletely mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,1,2,13,14,19,34]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[25]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[3,4,17,19,24,32,34]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,13,26,28]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[29,42]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[11,26,28,43]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[10]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[7,43]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[7]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[29,36,42]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[3,4,17,19,24,34]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[18,26,28]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[9,16,23,27,34]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[26,28]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[5,6,31,36]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[12,16,36,39]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[17,29,42]}],"complexes":["SET complex","RAG1/2-RSS recombinase complex","HMGB2/SRC-1/ER complex","TFIID-TFIIA preinitiation complex"],"partners":["RAG1","SET","TP73","LEF1","SRC-1","OCT4","C/EBPB","GFI1B"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P26583","full_name":"High mobility group protein B2","aliases":["High mobility group protein 2","HMG-2"],"length_aa":209,"mass_kda":24.0,"function":"Multifunctional protein with various roles in different cellular compartments. May act in a redox sensitive manner. In the nucleus is an abundant chromatin-associated non-histone protein involved in transcription, chromatin remodeling and V(D)J recombination and probably other processes. Binds DNA with a preference to non-canonical DNA structures such as single-stranded DNA. Can bent DNA and enhance DNA flexibility by looping thus providing a mechanism to promote activities on various gene promoters by enhancing transcription factor binding and/or bringing distant regulatory sequences into close proximity (PubMed:11909973, PubMed:18413230, PubMed:19522541, PubMed:19965638, PubMed:20123072, PubMed:7797075). Involved in V(D)J recombination by acting as a cofactor of the RAG complex: acts by stimulating cleavage and RAG protein binding at the 23 bp spacer of conserved recombination signal sequences (RSS) (By similarity). Proposed to be involved in the innate immune response to nucleic acids by acting as a promiscuous immunogenic DNA/RNA sensor which cooperates with subsequent discriminative sensing by specific pattern recognition receptors (By similarity). In the extracellular compartment acts as a chemokine. Promotes proliferation and migration of endothelial cells implicating AGER/RAGE (PubMed:19811285). Has antimicrobial activity in gastrointestinal epithelial tissues (PubMed:23877675). Involved in inflammatory response to antigenic stimulus coupled with pro-inflammatory activity (By similarity). Involved in modulation of neurogenesis probably by regulation of neural stem proliferation (By similarity). Involved in articular cartilage surface maintenance implicating LEF1 and the Wnt/beta-catenin pathway (By similarity)","subcellular_location":"Nucleus; Chromosome; Cytoplasm; Secreted","url":"https://www.uniprot.org/uniprotkb/P26583/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HMGB2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000164104","cell_line_id":"CID001755","localizations":[{"compartment":"nucleoplasm","grade":3},{"compartment":"chromatin","grade":2}],"interactors":[{"gene":"RPS19","stoichiometry":10.0},{"gene":"RPLP2","stoichiometry":10.0},{"gene":"RPL39P5;RPL39","stoichiometry":4.0},{"gene":"GNB2L1","stoichiometry":4.0},{"gene":"RPL8","stoichiometry":4.0},{"gene":"RPL10A","stoichiometry":4.0},{"gene":"RPS20","stoichiometry":4.0},{"gene":"RPL27","stoichiometry":4.0},{"gene":"RPS6","stoichiometry":4.0},{"gene":"RPS25","stoichiometry":4.0}],"url":"https://opencell.sf.czbiohub.org/target/CID001755","total_profiled":1310},"omim":[{"mim_id":"606009","title":"DOUBLE HOMEOBOX PROTEIN 4; DUX4","url":"https://www.omim.org/entry/606009"},{"mim_id":"602700","title":"E1A-BINDING PROTEIN, 300-KD; EP300","url":"https://www.omim.org/entry/602700"},{"mim_id":"601425","title":"TRANSCRIPTION ELONGATION FACTOR A, 1; TCEA1","url":"https://www.omim.org/entry/601425"},{"mim_id":"300193","title":"HIGH MOBILITY GROUP BOX 3; HMGB3","url":"https://www.omim.org/entry/300193"},{"mim_id":"163906","title":"HIGH MOBILITY GROUP BOX 2; HMGB2","url":"https://www.omim.org/entry/163906"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nucleoli","reliability":"Additional"},{"location":"Principal piece","reliability":"Additional"},{"location":"Annulus","reliability":"Additional"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"bone marrow","ntpm":2214.7},{"tissue":"lymphoid tissue","ntpm":874.1}],"url":"https://www.proteinatlas.org/search/HMGB2"},"hgnc":{"alias_symbol":[],"prev_symbol":["HMG2"]},"alphafold":{"accession":"P26583","domains":[{"cath_id":"1.10.30.10","chopping":"14-76","consensus_level":"high","plddt":89.464,"start":14,"end":76},{"cath_id":"1.10.30.10","chopping":"100-170","consensus_level":"high","plddt":90.1,"start":100,"end":170}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P26583","model_url":"https://alphafold.ebi.ac.uk/files/AF-P26583-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P26583-F1-predicted_aligned_error_v6.png","plddt_mean":77.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HMGB2","jax_strain_url":"https://www.jax.org/strain/search?query=HMGB2"},"sequence":{"accession":"P26583","fasta_url":"https://rest.uniprot.org/uniprotkb/P26583.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P26583/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P26583"}},"corpus_meta":[{"pmid":"8339930","id":"PMC_8339930","title":"The nonspecific DNA-binding and -bending proteins HMG1 and HMG2 promote the assembly of complex nucleoprotein structures.","date":"1993","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/8339930","citation_count":309,"is_preprint":false},{"pmid":"628842","id":"PMC_628842","title":"Nonhistone proteins HMG1 and HMG2 change the DNA helical structure.","date":"1978","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/628842","citation_count":223,"is_preprint":false},{"pmid":"25996293","id":"PMC_25996293","title":"miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2.","date":"2015","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/25996293","citation_count":191,"is_preprint":false},{"pmid":"29706538","id":"PMC_29706538","title":"HMGB2 Loss upon Senescence Entry Disrupts Genomic Organization and Induces CTCF Clustering across Cell Types.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/29706538","citation_count":175,"is_preprint":false},{"pmid":"11262228","id":"PMC_11262228","title":"Reduced fertility and spermatogenesis defects in mice lacking chromosomal protein Hmgb2.","date":"2001","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11262228","citation_count":173,"is_preprint":false},{"pmid":"11748232","id":"PMC_11748232","title":"HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11748232","citation_count":164,"is_preprint":false},{"pmid":"27799366","id":"PMC_27799366","title":"HMGB2 orchestrates the chromatin landscape of senescence-associated secretory phenotype gene loci.","date":"2016","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27799366","citation_count":139,"is_preprint":false},{"pmid":"7797075","id":"PMC_7797075","title":"Activation of the TFIID-TFIIA complex with HMG-2.","date":"1995","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/7797075","citation_count":131,"is_preprint":false},{"pmid":"11909973","id":"PMC_11909973","title":"HMG2 interacts with the nucleosome assembly protein SET and is a target of the cytotoxic T-lymphocyte protease granzyme A.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11909973","citation_count":118,"is_preprint":false},{"pmid":"19139395","id":"PMC_19139395","title":"Aging-related loss of the chromatin protein HMGB2 in articular cartilage is linked to reduced cellularity and osteoarthritis.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19139395","citation_count":118,"is_preprint":false},{"pmid":"2583185","id":"PMC_2583185","title":"Tissue specificity of nucleo-cytoplasmic distribution of HMG1 and HMG2 proteins and their probable functions.","date":"1989","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2583185","citation_count":113,"is_preprint":false},{"pmid":"12925773","id":"PMC_12925773","title":"Association of chromatin proteins high mobility group box (HMGB) 1 and HMGB2 with mitotic chromosomes.","date":"2003","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/12925773","citation_count":110,"is_preprint":false},{"pmid":"10490593","id":"PMC_10490593","title":"The RAG1 homeodomain recruits HMG1 and HMG2 to facilitate recombination signal sequence binding and to enhance the intrinsic DNA-bending activity of RAG1-RAG2.","date":"1999","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10490593","citation_count":106,"is_preprint":false},{"pmid":"226939","id":"PMC_226939","title":"Nonhistone proteins HMG1 and HMG2 unwind DNA double helix.","date":"1979","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/226939","citation_count":94,"is_preprint":false},{"pmid":"25937287","id":"PMC_25937287","title":"Antisense RNA controls LRP1 Sense transcript expression through interaction with a chromatin-associated protein, HMGB2.","date":"2015","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/25937287","citation_count":87,"is_preprint":false},{"pmid":"29463261","id":"PMC_29463261","title":"HMGB2 is associated with malignancy and regulates Warburg effect by targeting LDHB and FBP1 in breast cancer.","date":"2018","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/29463261","citation_count":75,"is_preprint":false},{"pmid":"6458811","id":"PMC_6458811","title":"Loss of chromosomal high mobility group proteins HMG1 and HMG2 when mouse neuroblastoma and Friend erythroleukemia cells become committed to differentiation.","date":"1981","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/6458811","citation_count":71,"is_preprint":false},{"pmid":"19805379","id":"PMC_19805379","title":"Chromatin protein HMGB2 regulates articular cartilage surface maintenance via beta-catenin pathway.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19805379","citation_count":69,"is_preprint":false},{"pmid":"9010268","id":"PMC_9010268","title":"Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2.","date":"1997","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9010268","citation_count":67,"is_preprint":false},{"pmid":"9558172","id":"PMC_9558172","title":"Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases.","date":"1998","source":"The Journal of rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/9558172","citation_count":61,"is_preprint":false},{"pmid":"15833996","id":"PMC_15833996","title":"Dual binding modes for an HMG domain from human HMGB2 on DNA.","date":"2005","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15833996","citation_count":61,"is_preprint":false},{"pmid":"10390537","id":"PMC_10390537","title":"A dimer of the lymphoid protein RAG1 recognizes the recombination signal sequence and the complex stably incorporates the high mobility group protein HMG2.","date":"1999","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/10390537","citation_count":59,"is_preprint":false},{"pmid":"2350545","id":"PMC_2350545","title":"Primary structure of non-histone chromosomal protein HMG2 revealed by the nucleotide sequence.","date":"1990","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2350545","citation_count":59,"is_preprint":false},{"pmid":"37176041","id":"PMC_37176041","title":"Structure and Functions of HMGB2 Protein.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37176041","citation_count":57,"is_preprint":false},{"pmid":"28396617","id":"PMC_28396617","title":"Long non-coding RNA MALAT1 drives gastric cancer progression by regulating HMGB2 modulating the miR-1297.","date":"2017","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/28396617","citation_count":57,"is_preprint":false},{"pmid":"8007973","id":"PMC_8007973","title":"Repression of basal transcription by HMG2 is counteracted by TFIIH-associated factors in an ATP-dependent process.","date":"1994","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8007973","citation_count":56,"is_preprint":false},{"pmid":"28069585","id":"PMC_28069585","title":"Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer.","date":"2017","source":"Acta biochimica et biophysica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/28069585","citation_count":52,"is_preprint":false},{"pmid":"10323891","id":"PMC_10323891","title":"High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis.","date":"1999","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/10323891","citation_count":48,"is_preprint":false},{"pmid":"30575817","id":"PMC_30575817","title":"Long noncoding RNA CRCMSL suppresses tumor invasive and metastasis in colorectal carcinoma through nucleocytoplasmic shuttling of HMGB2.","date":"2018","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/30575817","citation_count":47,"is_preprint":false},{"pmid":"30657566","id":"PMC_30657566","title":"The lncRNA HOXA11-AS promotes glioma cell growth and metastasis by targeting miR-130a-5p/HMGB2.","date":"2019","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30657566","citation_count":46,"is_preprint":false},{"pmid":"21890638","id":"PMC_21890638","title":"Expression patterns and function of chromatin protein HMGB2 during mesenchymal stem cell differentiation.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21890638","citation_count":45,"is_preprint":false},{"pmid":"30699189","id":"PMC_30699189","title":"Oncogenic KSHV-encoded interferon regulatory factor upregulates HMGB2 and CMPK1 expression to promote cell invasion by disrupting a complex lncRNA-OIP5-AS1/miR-218-5p network.","date":"2019","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/30699189","citation_count":44,"is_preprint":false},{"pmid":"23259547","id":"PMC_23259547","title":"Positive genetic interactors of HMG2 identify a new set of genetic perturbations for improving sesquiterpene production in Saccharomyces cerevisiae.","date":"2012","source":"Microbial cell factories","url":"https://pubmed.ncbi.nlm.nih.gov/23259547","citation_count":44,"is_preprint":false},{"pmid":"20550581","id":"PMC_20550581","title":"Observations on squalene accumulation in Saccharomyces cerevisiae due to the manipulation of HMG2 and ERG6.","date":"2010","source":"FEMS yeast research","url":"https://pubmed.ncbi.nlm.nih.gov/20550581","citation_count":44,"is_preprint":false},{"pmid":"19223331","id":"PMC_19223331","title":"HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase IIalpha.","date":"2009","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/19223331","citation_count":41,"is_preprint":false},{"pmid":"23495099","id":"PMC_23495099","title":"Oct4 interaction with Hmgb2 regulates Akt signaling and pluripotency.","date":"2013","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/23495099","citation_count":40,"is_preprint":false},{"pmid":"39030964","id":"PMC_39030964","title":"Targeting N4-acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2-mediated HMGB2 mRNA translation.","date":"2024","source":"Cancer communications (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/39030964","citation_count":39,"is_preprint":false},{"pmid":"28183701","id":"PMC_28183701","title":"Association of Serum HMGB2 Levels With In-Stent Restenosis: HMGB2 Promotes Neointimal Hyperplasia in Mice With Femoral Artery Injury and Proliferation and Migration of VSMCs.","date":"2017","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28183701","citation_count":38,"is_preprint":false},{"pmid":"19522541","id":"PMC_19522541","title":"Nucleosome binding properties and Co-remodeling activities of native and in vivo acetylated HMGB-1 and HMGB-2 proteins.","date":"2009","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19522541","citation_count":38,"is_preprint":false},{"pmid":"9888798","id":"PMC_9888798","title":"Differences in DNA recognition and conformational change activity between boxes A and B in HMG2 protein.","date":"1999","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9888798","citation_count":37,"is_preprint":false},{"pmid":"1551873","id":"PMC_1551873","title":"Structure of a gene coding for human HMG2 protein.","date":"1992","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1551873","citation_count":37,"is_preprint":false},{"pmid":"28011583","id":"PMC_28011583","title":"Association of serum HMGB2 level with MACE at 1 mo of myocardial infarction: Aggravation of myocardial ischemic injury in rats by HMGB2 via ROS.","date":"2016","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/28011583","citation_count":37,"is_preprint":false},{"pmid":"9784391","id":"PMC_9784391","title":"Identification of the nuclear factor HMG2 as an activator for DFF nuclease activity.","date":"1998","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9784391","citation_count":37,"is_preprint":false},{"pmid":"37704621","id":"PMC_37704621","title":"HMGB2 regulates the differentiation and stemness of exhausted CD8+ T cells during chronic viral infection and cancer.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37704621","citation_count":35,"is_preprint":false},{"pmid":"25284587","id":"PMC_25284587","title":"Genomic interaction between ER and HMGB2 identifies DDX18 as a novel driver of endocrine resistance in breast cancer cells.","date":"2014","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/25284587","citation_count":35,"is_preprint":false},{"pmid":"913411","id":"PMC_913411","title":"Interaction of non-histone chromosomal proteins HMG1 and HMG2 with DNA.","date":"1977","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/913411","citation_count":34,"is_preprint":false},{"pmid":"32391592","id":"PMC_32391592","title":"MicroRNA-127-5p impairs function of granulosa cells via HMGB2 gene in premature ovarian insufficiency.","date":"2020","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32391592","citation_count":34,"is_preprint":false},{"pmid":"23255232","id":"PMC_23255232","title":"High-mobility group box 2 (HMGB2) modulates radioresponse and is downregulated by p53 in colorectal cancer cell.","date":"2012","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/23255232","citation_count":34,"is_preprint":false},{"pmid":"19965638","id":"PMC_19965638","title":"High-mobility group protein HMGB2 regulates human erythroid differentiation through trans-activation of GFI1B transcription.","date":"2009","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19965638","citation_count":32,"is_preprint":false},{"pmid":"25327479","id":"PMC_25327479","title":"Silencing of high-mobility group box 2 (HMGB2) modulates cisplatin and 5-fluorouracil sensitivity in head and neck squamous cell carcinoma.","date":"2015","source":"Proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/25327479","citation_count":32,"is_preprint":false},{"pmid":"21628456","id":"PMC_21628456","title":"The sterol-sensing domain (SSD) directly mediates signal-regulated endoplasmic reticulum-associated degradation (ERAD) of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase isozyme Hmg2.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21628456","citation_count":32,"is_preprint":false},{"pmid":"27672022","id":"PMC_27672022","title":"HMGB2 regulates satellite-cell-mediated skeletal muscle regeneration through IGF2BP2.","date":"2016","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/27672022","citation_count":30,"is_preprint":false},{"pmid":"7758147","id":"PMC_7758147","title":"Differential expression of nuclear HMG1, HMG2 proteins and H1(zero) histone in various blood cells.","date":"1995","source":"Cell biochemistry and function","url":"https://pubmed.ncbi.nlm.nih.gov/7758147","citation_count":30,"is_preprint":false},{"pmid":"6458621","id":"PMC_6458621","title":"Comparative studies on microinjected high-mobility-group chromosomal proteins, HMG1 and HMG2.","date":"1981","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/6458621","citation_count":30,"is_preprint":false},{"pmid":"24391977","id":"PMC_24391977","title":"Aberrant neural stem cell proliferation and increased adult neurogenesis in mice lacking chromatin protein HMGB2.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24391977","citation_count":30,"is_preprint":false},{"pmid":"28771884","id":"PMC_28771884","title":"HMGB2 expression is associated with transition from a quiescent to an activated state of adult neural stem cells.","date":"2017","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/28771884","citation_count":30,"is_preprint":false},{"pmid":"33658008","id":"PMC_33658008","title":"microRNA-130a-5p suppresses myocardial ischemia reperfusion injury by downregulating the HMGB2/NF-κB axis.","date":"2021","source":"BMC cardiovascular disorders","url":"https://pubmed.ncbi.nlm.nih.gov/33658008","citation_count":30,"is_preprint":false},{"pmid":"16098203","id":"PMC_16098203","title":"Recombinant derivatives of the human high-mobility group protein HMGB2 mediate efficient nonviral gene delivery.","date":"2005","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/16098203","citation_count":29,"is_preprint":false},{"pmid":"23756189","id":"PMC_23756189","title":"Characterizations of two grass carp Ctenopharyngodon idella HMGB2 genes and potential roles in innate immunity.","date":"2013","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23756189","citation_count":29,"is_preprint":false},{"pmid":"35091064","id":"PMC_35091064","title":"HMGB2 causes photoreceptor death via down-regulating Nrf2/HO-1 and up-regulating NF-κB/NLRP3 signaling pathways in light-induced retinal degeneration model.","date":"2022","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35091064","citation_count":28,"is_preprint":false},{"pmid":"9166769","id":"PMC_9166769","title":"Nuclear accumulation of HMG2 protein is mediated by basic regions interspaced with a long DNA-binding sequence, and retention within the nucleus requires the acidic carboxyl terminus.","date":"1997","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9166769","citation_count":28,"is_preprint":false},{"pmid":"11041984","id":"PMC_11041984","title":"High affinity binding of proteins HMG1 and HMG2 to semicatenated DNA loops.","date":"2000","source":"BMC molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11041984","citation_count":28,"is_preprint":false},{"pmid":"27799373","id":"PMC_27799373","title":"HMGB2 holds the key to the senescence-associated secretory phenotype.","date":"2016","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27799373","citation_count":28,"is_preprint":false},{"pmid":"9617797","id":"PMC_9617797","title":"Abundance of mRNAs encoding HMG1/HMG2 class high-mobility-group DNA-binding proteins are differentially regulated in cotyledons of Pharbitis nil.","date":"1998","source":"Plant molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9617797","citation_count":27,"is_preprint":false},{"pmid":"31219186","id":"PMC_31219186","title":"MicroRNA-329 upregulation impairs the HMGB2/β-catenin pathway and regulates cell biological behaviors in melanoma.","date":"2019","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31219186","citation_count":26,"is_preprint":false},{"pmid":"7763232","id":"PMC_7763232","title":"Repression of cell cycle progression by antisense HMG2 RNA.","date":"1995","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/7763232","citation_count":26,"is_preprint":false},{"pmid":"34215724","id":"PMC_34215724","title":"HMGB2 orchestrates mitotic clonal expansion by binding to the promoter of C/EBPβ to facilitate adipogenesis.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/34215724","citation_count":26,"is_preprint":false},{"pmid":"18400754","id":"PMC_18400754","title":"High mobility group protein HMGB2 is a critical regulator of plasmodium oocyst development.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18400754","citation_count":26,"is_preprint":false},{"pmid":"30119172","id":"PMC_30119172","title":"Involvement of JNK1/2-NF-κBp65 in the regulation of HMGB2 in myocardial ischemia/reperfusion-induced apoptosis in human AC16 cardiomyocytes.","date":"2018","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/30119172","citation_count":26,"is_preprint":false},{"pmid":"6235858","id":"PMC_6235858","title":"Isolation of high-mobility-group proteins HMG1 and HMG2 in non denaturing conditions and comparison of their properties with those of acid-extracted proteins.","date":"1984","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/6235858","citation_count":26,"is_preprint":false},{"pmid":"33707625","id":"PMC_33707625","title":"The LncRNA RP11-301G19.1/miR-582-5p/HMGB2 axis modulates the proliferation and apoptosis of multiple myeloma cancer cells via the PI3K/AKT signalling pathway.","date":"2021","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33707625","citation_count":25,"is_preprint":false},{"pmid":"20036050","id":"PMC_20036050","title":"HMGB2 stabilizes p53 by interfering with E6/E6AP-mediated p53 degradation in human papillomavirus-positive HeLa cells.","date":"2009","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/20036050","citation_count":25,"is_preprint":false},{"pmid":"38148870","id":"PMC_38148870","title":"HMGB2 Deficiency Mitigates Abdominal Aortic Aneurysm by Suppressing Ang-II-Caused Ferroptosis and Inflammation via NF-κβ Pathway.","date":"2023","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/38148870","citation_count":24,"is_preprint":false},{"pmid":"23306196","id":"PMC_23306196","title":"Insulin-induced gene protein (INSIG)-dependent sterol regulation of Hmg2 endoplasmic reticulum-associated degradation (ERAD) in yeast.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23306196","citation_count":24,"is_preprint":false},{"pmid":"31103821","id":"PMC_31103821","title":"Involvement of microRNA-23b-5p in the promotion of cardiac hypertrophy and dysfunction via the HMGB2 signaling pathway.","date":"2019","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/31103821","citation_count":24,"is_preprint":false},{"pmid":"12591612","id":"PMC_12591612","title":"Molecular characterization of three 3-hydroxy-3-methylglutaryl-CoA reductase genes including pathogen-induced Hmg2 from pepper (Capsicum annuum).","date":"2003","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/12591612","citation_count":24,"is_preprint":false},{"pmid":"31171637","id":"PMC_31171637","title":"Latexin regulation by HMGB2 is required for hematopoietic stem cell maintenance.","date":"2019","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/31171637","citation_count":23,"is_preprint":false},{"pmid":"2465778","id":"PMC_2465778","title":"Nonhistone proteins HMG1 and HMG2 suppress the nucleosome assembly at physiological ionic strength.","date":"1989","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/2465778","citation_count":23,"is_preprint":false},{"pmid":"36834988","id":"PMC_36834988","title":"Structural Characteristics of High-Mobility Group Proteins HMGB1 and HMGB2 and Their Interaction with DNA.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36834988","citation_count":22,"is_preprint":false},{"pmid":"30886640","id":"PMC_30886640","title":"6-Gingerol Attenuates Ischemia-Reperfusion-Induced Cell Apoptosis in Human AC16 Cardiomyocytes through HMGB2-JNK1/2-NF-κB Pathway.","date":"2019","source":"Evidence-based complementary and alternative medicine : eCAM","url":"https://pubmed.ncbi.nlm.nih.gov/30886640","citation_count":22,"is_preprint":false},{"pmid":"34699756","id":"PMC_34699756","title":"LncRNA SNHG16 accelerates atherosclerosis and promotes ox-LDL-induced VSMC growth via the miRNA-22-3p/HMGB2 axis.","date":"2021","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34699756","citation_count":21,"is_preprint":false},{"pmid":"10501034","id":"PMC_10501034","title":"Hmg-coA reductase gene family in cotton (Gossypium hirsutum L.): unique structural features and differential expression of hmg2 potentially associated with synthesis of specific isoprenoids in developing embryos.","date":"1999","source":"Plant & cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10501034","citation_count":21,"is_preprint":false},{"pmid":"4084291","id":"PMC_4084291","title":"Differential binding of chromosomal proteins HMG1 and HMG2 to superhelical DNA.","date":"1985","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/4084291","citation_count":21,"is_preprint":false},{"pmid":"28851665","id":"PMC_28851665","title":"Downregulation of miR-130a promotes cell growth and epithelial to mesenchymal transition by activating HMGB2 in glioma.","date":"2017","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/28851665","citation_count":20,"is_preprint":false},{"pmid":"22644337","id":"PMC_22644337","title":"Anti-high mobility group box 1 and box 2 non-histone chromosomal proteins (HMGB1/HMGB2) antibodies and anti-Saccharomyces cerevisiae antibodies (ASCA): accuracy in differentially diagnosing UC and CD and correlation with inflammatory bowel disease phenotype.","date":"2012","source":"Journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/22644337","citation_count":20,"is_preprint":false},{"pmid":"32982307","id":"PMC_32982307","title":"Long Noncoding RNA PART1 Promotes Hepatocellular Carcinoma Progression via Targeting miR-590-3p/HMGB2 Axis.","date":"2020","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32982307","citation_count":20,"is_preprint":false},{"pmid":"6221763","id":"PMC_6221763","title":"Comparisons of the structures of the chromosomal high mobility group proteins HMG1 and HMG2 prepared under conditions of neutral and acidic pH.","date":"1983","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/6221763","citation_count":20,"is_preprint":false},{"pmid":"29651745","id":"PMC_29651745","title":"Correlations between age, functional status, and the senescence-associated proteins HMGB2 and p16INK4a.","date":"2018","source":"GeroScience","url":"https://pubmed.ncbi.nlm.nih.gov/29651745","citation_count":19,"is_preprint":false},{"pmid":"8679707","id":"PMC_8679707","title":"Intracellular distribution of HMG1, HMG2 and UBF change following treatment with cisplatin.","date":"1996","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/8679707","citation_count":19,"is_preprint":false},{"pmid":"3816775","id":"PMC_3816775","title":"Interaction of non-histone proteins HMG1 and HMG2 with core histones in nucleosomes and core particles revealed by chemical cross-linking.","date":"1987","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/3816775","citation_count":19,"is_preprint":false},{"pmid":"35831365","id":"PMC_35831365","title":"Spatiotemporal expression of HMGB2 regulates cell proliferation and hepatocyte size during liver regeneration.","date":"2022","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/35831365","citation_count":18,"is_preprint":false},{"pmid":"30487376","id":"PMC_30487376","title":"Loss of Endogenous HMGB2 Promotes Cardiac Dysfunction and Pressure Overload-Induced Heart Failure in Mice.","date":"2018","source":"Circulation journal : official journal of the Japanese Circulation Society","url":"https://pubmed.ncbi.nlm.nih.gov/30487376","citation_count":18,"is_preprint":false},{"pmid":"31661640","id":"PMC_31661640","title":"HMGB2 is a negative regulator of telomerase activity in human embryonic stem and progenitor cells.","date":"2019","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/31661640","citation_count":18,"is_preprint":false},{"pmid":"29942000","id":"PMC_29942000","title":"HMGB2 is a novel adipogenic factor that regulates ectopic fat infiltration in skeletal muscles.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29942000","citation_count":18,"is_preprint":false},{"pmid":"8975778","id":"PMC_8975778","title":"Differential binding of HMG1, HMG2, and a single HMG box to cisplatin-damaged DNA.","date":"1996","source":"Toxicology and applied pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/8975778","citation_count":18,"is_preprint":false},{"pmid":"37930124","id":"PMC_37930124","title":"HMGB2 is a potential diagnostic marker and therapeutic target for liver fibrosis and cirrhosis.","date":"2023","source":"Hepatology communications","url":"https://pubmed.ncbi.nlm.nih.gov/37930124","citation_count":17,"is_preprint":false},{"pmid":"39354146","id":"PMC_39354146","title":"HMGB2-induced calreticulin translocation required for immunogenic cell death and ferroptosis of cancer cells are controlled by the nuclear exporter XPO1.","date":"2024","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/39354146","citation_count":16,"is_preprint":false},{"pmid":"25916985","id":"PMC_25916985","title":"Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.","date":"2015","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/25916985","citation_count":16,"is_preprint":false},{"pmid":"29050221","id":"PMC_29050221","title":"PDGFRA, HSD17B4 and HMGB2 are potential therapeutic targets in polycystic ovarian syndrome and breast cancer.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29050221","citation_count":16,"is_preprint":false},{"pmid":"34894065","id":"PMC_34894065","title":"β-Amyrin ameliorates diabetic nephropathy in mice and regulates the miR-181b-5p/HMGB2 axis in high glucose-stimulated HK-2 cells.","date":"2021","source":"Environmental toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/34894065","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49695,"output_tokens":11735,"usd":0.162555,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":22912,"output_tokens":5859,"usd":0.130518,"stage2_stop_reason":"end_turn"},"total_usd":0.293073,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"HMGB2 (HMG2) bends DNA extremely efficiently, forming circles as small as 66 bp, and can substitute for prokaryotic HU protein in promoting assembly of complex nucleoprotein invertasome structures, with HMG box domain B being sufficient for both bending and invertasome assembly.\",\n      \"method\": \"Ligase-mediated circularization assay, invertasome assembly assay, partial proteolytic digestion domain analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with domain-mapping by proteolysis, multiple orthogonal assays, replicated across different substrates\",\n      \"pmids\": [\"8339930\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1978,\n      \"finding\": \"HMG2 reduces the linking number of circular DNA when covalent closure occurs in its presence, indicating the protein unwinds the DNA double helix or induces supercoiling.\",\n      \"method\": \"Topological winding number assay with circular DNA and DNA ligase\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro biochemical assay, foundational finding replicated in subsequent studies\",\n      \"pmids\": [\"628842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1979,\n      \"finding\": \"HMG2 unwinds the DNA double helix by local denaturation of base pairs; HMG2 shows higher affinity for single-stranded than double-stranded DNA in the presence of salt; the net unwinding angle is 26° per molecule of HMG2.\",\n      \"method\": \"Melting absorption technique, competition unwinding experiments measuring topological winding number\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro biochemical measurement, multiple quantitative methods\",\n      \"pmids\": [\"226939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"HMG2 activates transcription in a defined in vitro RNA polymerase II system by stabilizing an activated conformation of the TFIID-TFIIA-promoter complex; activation requires TFIIA and TAF-containing TFIID, and results in slower TFIIB dissociation from the preinitiation complex.\",\n      \"method\": \"Defined in vitro transcription reconstitution assay with purified factors, order-of-addition experiments, titration experiments\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — fully reconstituted in vitro transcription system with purified components and multiple mechanistic tests\",\n      \"pmids\": [\"7797075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"HMG2 acts as a basal repressor of class II gene transcription by inhibiting steps after TBP-TFIIA-promoter complex assembly but before the fourth phosphodiester bond is formed; a TFIIH-associated factor counteracts this repression in an ATP/dATP-dependent manner.\",\n      \"method\": \"In vitro transcription assay with purified factors, order-of-addition experiments, antibody depletion of TFIIH, ATP analog inhibition\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted in vitro transcription with purified components, multiple mechanistic experiments including antibody depletion and nucleotide specificity tests\",\n      \"pmids\": [\"8007973\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The RAG1 homeodomain directly interacts with both HMG boxes of HMG2; this interaction facilitates RAG1/2 binding to recombination signal sequences (RSS) by promoting high-affinity binding to the nonamer motif, and HMG2 significantly enhances bending of the 23RSS.\",\n      \"method\": \"Protein-protein interaction assay, circular permutation DNA bending assay, electrophoretic mobility shift assay, in vivo V(D)J recombination assay in transfected cells\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct protein interaction demonstrated, multiple orthogonal methods including in vitro binding, bending assay, and in vivo recombination readout\",\n      \"pmids\": [\"10490593\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"HMG2 is stably incorporated into the RAG1/RSS complex; it can increase the affinity of RAG1 for the RSS even in the absence of RAG2. Core RAG1 exists as a dimer both free in solution and as the minimal species bound to the RSS.\",\n      \"method\": \"Electrophoretic mobility shift assay (EMSA), recombinant protein expression, zinc analysis, cleavage activity assay\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct binding and functional assays with recombinant proteins, multiple orthogonal methods\",\n      \"pmids\": [\"10390537\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"HMG2 is a component of the SET complex (270–420 kDa endoplasmic reticulum-associated complex containing SET, pp32, and APE); it coprecipitates with SET and colocalizes with SET at the endoplasmic reticulum in the cytoplasm. Cytoplasmic HMG2 mediates DNA binding and bending activity within the SET complex. HMG2 is a physiologically relevant granzyme A substrate; granzyme A cleaves HMG2 after Lys65 within HMG box A, destroying its DNA binding and bending functions.\",\n      \"method\": \"Co-immunoprecipitation, confocal microscopy colocalization, in vitro granzyme A cleavage assay, DNA binding/bending assays, single-stranded DNA nicking assay in isolated nuclei\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, colocalization, in vitro cleavage assay with functional readout, multiple orthogonal methods in single study\",\n      \"pmids\": [\"11909973\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"HMGB2 physically interacts with p73α and p73β (pull-down assay); both HMG box domains A and B of HMGB1 interact with p73α; endogenous or ectopically expressed HMGB2 cell-specifically inhibits p73α/β- and p53-dependent transactivation from the Bax gene promoter in SAOS-2 cells, while stimulating it in H1299 cells.\",\n      \"method\": \"Pull-down assay, gel-shift assay (EMSA), transient transfection with luciferase reporter, antisense knockdown\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pull-down, EMSA, and functional reporter assays in multiple cell lines with antisense knockdown, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"11748232\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Hmgb2 knockout mice are viable but male Hmgb2-/- mice have reduced fertility associated with Sertoli and germ cell degeneration and immotile spermatozoa; in adult mice Hmgb2 is restricted to lymphoid organs and testes, though widely expressed during embryogenesis, indicating a specialized role in germ cell differentiation.\",\n      \"method\": \"Gene knockout (Hmgb2-/- mice), histological analysis, immunohistochemistry, fertility assay\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic knockout with specific cellular phenotype, replicated across multiple tissue analyses\",\n      \"pmids\": [\"11262228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"HMGB1 and HMGB2 are present in mitotic cells in two forms—free and chromatin-associated—that rapidly exchange; two sites encompassing HMG-box A and B are responsible for mitotic chromosome binding; previous immunofluorescence reports of dissociation from chromosomes during mitosis were artifacts of cell permeabilization or chemical fixation.\",\n      \"method\": \"Live-cell imaging with GFP/DsRed-tagged proteins, fluorescence recovery after photobleaching (FRAP), permeabilization controls\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — live imaging with domain mapping, rigorous controls showing fixation artifacts, direct functional consequence for subcellular localization\",\n      \"pmids\": [\"12925773\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Nuclear accumulation of HMG2 is mediated by basic regions interspaced with the HMG box DNA-binding sequence (a novel nuclear localization signal distinct from classic basic clusters); retention within the nucleus requires the acidic carboxyl terminus, as shown by interspecies heterokaryon assay.\",\n      \"method\": \"HMG2-β-galactosidase fusion protein expression in COS-7 cells, deletion analysis, interspecies heterokaryon assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — systematic deletion mapping of nuclear localization signal combined with heterokaryon retention assay\",\n      \"pmids\": [\"9166769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"HMG2 activates the nuclease activity of DFF40 (a caspase-3-activated apoptotic DNA fragmentation factor); bacterially expressed HMG2 enhances DFF40 nuclease activity in vitro, suggesting HMG proteins augment apoptotic DNA fragmentation through chromosomal structural changes.\",\n      \"method\": \"In vitro nuclease activity assay with purified recombinant proteins\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct in vitro functional assay with recombinant protein, single lab, single method\",\n      \"pmids\": [\"9784391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"HMG box B of HMG2 is the primary domain for DNA recognition and conformational changes (supercoiled DNA binding and DNA unwinding); box A requires the flanking basic linker region or box B to achieve full activity; Phe-102 in box B is predicted to intercalate into the base stack, whereas Ala-16 in box A is too small to intercalate.\",\n      \"method\": \"Gel retardation assay, DNA supercoiling assay, surface plasmon resonance (SPR), deletion/domain expression in E. coli, computer modeling\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro biochemical reconstitution with domain mutants and quantitative binding measurements (SPR), single lab but multiple orthogonal methods\",\n      \"pmids\": [\"9888798\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Isolated HMG box A from HMGB2 induces an average DNA bend angle of ~114° (at 50 mM Na+) via a flexible hinge mechanism at low concentrations; at higher concentrations, a cooperative filament binding mode is observed, distinct from the hinge mode.\",\n      \"method\": \"Single-molecule optical tweezers force-extension measurement of DNA\",\n      \"journal\": \"Biophysical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct single-molecule biophysical measurement with quantitative parameters, characterizes two binding modes\",\n      \"pmids\": [\"15833996\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HMGB1 and HMGB2 upregulate cellular expression of topoisomerase IIα; HMGB1/2 knockdown significantly decreases topo IIα mRNA and protein levels; the mechanism involves HMGB1/2 modulating binding of transcription factor NF-Y to the topo IIα promoter, and this effect is dependent on pRb status (active in pRb-negative cells).\",\n      \"method\": \"siRNA knockdown, luciferase reporter assay (topo IIα promoter), western blot, RT-PCR, pRb overexpression rescue experiment\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knockdown with mRNA and protein readouts, reporter assay, mechanistic link to NF-Y and pRb, single lab\",\n      \"pmids\": [\"19223331\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Age-related loss of HMGB2 in articular cartilage superficial zone is associated with reduced cellularity due to increased chondrocyte apoptosis; Hmgb2-/- mice show earlier onset and more severe osteoarthritis with increased cell death preceding glycosaminoglycan depletion.\",\n      \"method\": \"Hmgb2 knockout mice (Hmgb2-/-), histological analysis of cartilage, in vitro apoptosis assay of Hmgb2-/- chondrocytes\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with specific cellular phenotype (apoptosis) and in vitro validation, multiple readouts\",\n      \"pmids\": [\"19139395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HMGB2 enhances binding of Lef-1 to its target sequence and potentiates transcriptional activation of the Lef-1-β-catenin complex; the HMG domain within HMGB2 is required for interaction with Lef-1; HMGB2 and Wnt/β-catenin pathway co-localize in the superficial zone, and conditional deletion of β-catenin in chondrocytes induces apoptosis.\",\n      \"method\": \"Co-immunoprecipitation, ChIP, transcription reporter assay, conditional knockout of β-catenin in chondrocytes, immunofluorescence\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct protein interaction (Co-IP), functional reporter assay, domain mapping, in vivo conditional knockout, multiple orthogonal methods\",\n      \"pmids\": [\"19805379\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Acetylated forms of HMGB1 and HMGB2 (in vivo acetylated) acquire the ability to bind to nucleosome core particles (not shown for non-acetylated forms); acetylation increases binding to linker DNA-containing nucleosomes and enhances co-remodeling activity with SWI/SNF and RSC; acetylated HMGB1/2 also enhance SWI/SNF binding to nucleosomes without affecting ATPase activity.\",\n      \"method\": \"Nucleosome binding assay, nucleosome mobilization/sliding assay with SWI/SNF and RSC, ATPase assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct biochemical assays with native acetylated protein and remodeling complexes, single lab, multiple assays\",\n      \"pmids\": [\"19522541\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HMGB2 directly binds to the GFI1B promoter in vivo and up-regulates its transactivation, most likely by enhancing the binding of Oct-1 and GATA-1 to the GFI1B promoter; knockdown of HMGB2 in hematopoietic progenitor cells decreases Gfi-1B expression and impairs erythroid differentiation.\",\n      \"method\": \"ChIP (chromatin immunoprecipitation), luciferase reporter assay, siRNA knockdown, erythroid differentiation assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP demonstrates in vivo promoter binding, reporter assay shows functional consequence, knockdown with differentiation phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"19965638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"HMGB2 suppresses chondrogenic differentiation: lentiviral HMGB2 transduction of MSCs inhibits Col2a1 and Col10a1 expression, while Hmgb2-/- MSCs show enhanced Col10a1 and Runx2 expression; HMGB2 negatively regulates the stimulatory effect of Wnt/β-catenin signaling on the Runx2 proximal promoter.\",\n      \"method\": \"Lentiviral transduction, Hmgb2-/- MSC analysis, RT-PCR, luciferase reporter assay (Runx2 promoter), western blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — gain- and loss-of-function experiments with specific molecular readouts, multiple orthogonal methods, consistent in vitro and in vivo\",\n      \"pmids\": [\"21890638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"HMGB2 knockdown sensitizes colorectal cancer cells to ionizing radiation by increasing DNA damage and reducing DNA damage repair efficiency; p53 transcriptionally downregulates HMGB2 expression after radiation exposure, as shown by luciferase reporter assay (p53 reduces HMGB2 promoter activity) and by Nutlin-3/Tet-On p53 induction.\",\n      \"method\": \"shRNA knockdown, clonogenic survival assay, comet assay (DNA damage), luciferase reporter assay (HMGB2 promoter), Nutlin-3 treatment, Tet-On p53 induction system\",\n      \"journal\": \"Cancer biology & therapy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple experimental approaches (functional radiosensitization, reporter assay, small-molecule p53 activation, inducible p53 expression), single lab\",\n      \"pmids\": [\"23255232\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Oct4 post-translational modifications (phosphorylation) promote Akt activation and interaction of Oct4 with Hmgb2 and the SET complex, which preserves H3K27me3 marks in daughter cells and maintains pluripotency gene expression in murine embryonic stem cells.\",\n      \"method\": \"Co-immunoprecipitation, western blot (H3K27me3 ChIP), phosphorylation mutant analysis, Akt inhibition\",\n      \"journal\": \"Stem cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP demonstrates physical interaction, PTM mutants show functional consequence, single lab\",\n      \"pmids\": [\"23495099\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Hmgb2-/- mice exhibit subventricular zone hyperproliferation with increased numbers of neural stem cells and increased newly born neurons in the olfactory bulb; loss of HMGB2 is associated with upregulation of p21 and NCAM and downregulation of Oct4 in the SVZ.\",\n      \"method\": \"Hmgb2-/- mouse analysis, BrdU/Ki67 immunohistochemistry, western blot, neurosphere assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout with specific neurogenic phenotype, molecular marker analysis, single lab\",\n      \"pmids\": [\"24391977\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"HMGB2 forms a complex with SRC-1 and estrogen receptor (ER) at promoter regions of target genes in tamoxifen-resistant breast cancer cells; HMGB2 ChIPseq reveals distinct binding patterns between endocrine-sensitive and -resistant contexts; the HMGB2/SRC-1/ER complex targets the RNA helicase DDX18, whose modulation directly affects growth of tamoxifen-resistant cells.\",\n      \"method\": \"Co-immunoprecipitation (SRC-1/HMGB2), ChIP-seq (HMGB2), gene expression analysis, DDX18 knockdown proliferation assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-seq genome-wide binding, co-IP for complex validation, functional knockdown of downstream target, multiple orthogonal methods\",\n      \"pmids\": [\"25284587\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"HMGB2 directly binds to Lrp1-AS (a natural antisense lncRNA) and this interaction inhibits HMGB2's ability to enhance Srebp1a-dependent transcription of Lrp1; short oligonucleotides targeting Lrp1-AS inhibit the lncRNA-HMGB2 interaction and increase Lrp1 expression.\",\n      \"method\": \"RNA immunoprecipitation (RIP), in vitro binding assay, luciferase reporter assay (Lrp1 promoter), antisense oligonucleotide treatment\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct RNA-protein interaction demonstrated by RIP, functional reporter assay showing mechanistic consequence, oligonucleotide rescue experiment\",\n      \"pmids\": [\"25937287\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"HMGB2 preferentially localizes to SASP gene loci during senescence; loss of HMGB2 allows spreading of repressive heterochromatin into SASP gene loci, causing SASP gene loci to be incorporated into SAHFs and blunting SASP gene expression; HMGB2 thus acts as a boundary factor preventing heterochromatin spreading.\",\n      \"method\": \"ChIP-seq (HMGB2, H3K9me2/3, H3K27me3), immunofluorescence, siRNA knockdown, gene expression analysis\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide ChIP-seq showing localization to SASP loci, loss-of-function with specific heterochromatin spreading phenotype, multiple epigenomic methods\",\n      \"pmids\": [\"27799366\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"HMGB2 regulates myoblast proliferation and differentiation; knockdown of HMGB2 inhibits myoblast proliferation and stimulates differentiation by reducing Myf5 and cyclin A2 protein (not mRNA) levels; HMGB2 acts through transcriptional upregulation of IGF2BP2, an RNA-binding protein that enhances Myf5 translation and stabilizes cyclin A2 mRNA. In vivo HMGB2 depletion attenuates muscle regeneration and reduces satellite cell numbers.\",\n      \"method\": \"siRNA knockdown, lentiviral overexpression, western blot, RT-PCR, in vivo muscle injury model, ChIP, immunostaining\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — gain- and loss-of-function in vitro and in vivo, pathway placement via IGF2BP2 rescue experiments, multiple orthogonal methods\",\n      \"pmids\": [\"27672022\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Nuclear depletion of HMGB2 occurs early upon senescence entry and is sufficient to cause senescence-associated CTCF clustering and loop reshuffling; ectopic HMGB2 expression rescues these effects; HMGB2 loss is thus a mechanistic driver of 3D genome reorganization at senescence entry.\",\n      \"method\": \"Hi-C (3D genome), single-cell and population transcriptomics, live imaging, in silico modeling, HMGB2 knockdown, HMGB2 overexpression rescue across three cell types\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Hi-C genome reorganization data, knockdown and rescue in three independent cell types, multiple orthogonal methods\",\n      \"pmids\": [\"29706538\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"HMGB2 promotes neointimal hyperplasia and VSMC proliferation/migration by inducing reactive oxygen species through increased p47phox phosphorylation; these effects are mediated through RAGE (receptor for advanced glycation end products) but not TLR4, as shown by knockdown/knockout experiments.\",\n      \"method\": \"Hmgb2-/- mouse femoral artery injury model, perivascular HMGB2 administration, siRNA knockdown of p47phox and RAGE/TLR4, ROS measurement, VSMC proliferation/migration assay\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo knockout and gain-of-function, receptor knockdown/knockout discriminating RAGE from TLR4, ROS mechanism, multiple orthogonal methods\",\n      \"pmids\": [\"28183701\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HMGB2 stabilizes p53 protein in HPV-positive HeLa cells by interfering with HPV E6/E6AP-mediated ubiquitination and proteasomal degradation of p53; HMGB2 overexpression in HeLa cells causes p53 accumulation, G1 cell cycle arrest, and decreased proliferation; this effect is specific to HPV-positive cells.\",\n      \"method\": \"siRNA knockdown, overexpression, western blot (p53 protein level), ubiquitination assay, FACS cell cycle analysis\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain- and loss-of-function with p53 protein stability readout, ubiquitination assay, specific cell-type context validated, single lab\",\n      \"pmids\": [\"20036050\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HMGB2 is required for the differentiation and maintenance of stem-like progenitor exhausted CD8+ T cells (Tpex) during chronic viral infection and in tumors through epigenetic and transcriptional programming; Hmgb2-/- CD8+ T cells cannot sustain Tpex differentiation and long-term survival during persistent antigen despite expressing TCF-1 and TOX.\",\n      \"method\": \"Hmgb2-/- mice, chronic LCMV infection model, tumor models, flow cytometry, ATAC-seq, RNA-seq, single-cell analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout in multiple in vivo models (chronic infection and tumor), epigenomic (ATAC-seq) and transcriptomic evidence of programming role\",\n      \"pmids\": [\"37704621\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HMGB2 is a transcriptional suppressor of latexin; HMGB2 knockdown increases latexin expression and decreases hematopoietic stem cell (HSC) number and regeneration capacity in vivo; concomitant latexin blockade rescues HSC numbers; a functional SNP (rs31528793) in the latexin promoter differentially binds HMGB2 and affects promoter activity.\",\n      \"method\": \"DNA pull-down with mass spectrometry (identification), HMGB2 knockdown in mice, in vivo HSC number and regeneration assays, luciferase reporter assay (latexin promoter with SNP variants), western blot/RT-PCR\",\n      \"journal\": \"Haematologica\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — protein identified by DNA pull-down/MS, in vivo knockdown with HSC phenotype, mechanistic rescue, SNP-promoter reporter assay, multiple orthogonal methods\",\n      \"pmids\": [\"31171637\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HMGB2 is a negative regulator of telomerase activity in human embryonic stem cells and neuroectodermal cells; HMGB2 knockdown stimulates telomerase activity potentially through activation of PI3K/AKT/GSK3β/β-catenin pathways and augmented TERT transcription, while HMGB1 has the opposite (enhancing) effect on telomerase.\",\n      \"method\": \"Inducible shRNA knockdown in hESCs and neuroectodermal cells, telomerase activity assay (TRAP), RT-PCR for TERT/TERC, signaling pathway inhibition\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — inducible knockdown system with telomerase activity assay and pathway analysis, single lab, multiple cell types\",\n      \"pmids\": [\"31661640\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"HMGB2 mediates adipogenesis by binding to the C/EBPβ promoter at the sequence 'GGGTCTCAC' specifically during mitotic clonal expansion (MCE) stage, enhancing C/EBPβ expression; exogenous C/EBPβ rescues adipogenic impairment caused by HMGB2 depletion; Hmgb2-/- mice have decreased adipose tissue mass.\",\n      \"method\": \"Hmgb2-/- mice, ChIP (HMGB2 binding to C/EBPβ promoter), lentiviral overexpression/knockdown, C/EBPβ rescue experiment, qPCR, western blot, in vivo adipose tissue analysis\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct promoter occupancy by ChIP, rescue experiment, in vivo knockout phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"34215724\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"NAT10-mediated N4-acetylcytidine (ac4C) modification within the coding sequence (CDS) of HMGB2 mRNA enhances HMGB2 translation by facilitating binding of eukaryotic elongation factor 2 (eEF2) to the ac4C sites; this NAT10-ac4C/eEF2-HMGB2 axis promotes HCC proliferation and metastasis.\",\n      \"method\": \"acRIP-seq, RNA-seq, ribosome profiling, RNA immunoprecipitation, RNA pull-down, mass spectrometry, site-specific mutation, CETSA/DARTS drug binding assay, in vitro and in vivo HCC models\",\n      \"journal\": \"Cancer communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — epitranscriptomic sequencing (acRIP-seq) + ribosome profiling + RNA pull-down + site-specific mutation demonstrating mechanism, single lab but multiple orthogonal methods including functional rescue\",\n      \"pmids\": [\"39030964\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"HMGB2 secretion from the cell nucleus into the extracellular milieu is required for oxaliplatin-induced calreticulin (CRT) translocation to the plasma membrane (a required step for immunogenic cell death); nuclear export of HMGB2 is controlled by XPO1 (CRM1); XPO1 inhibition causes nuclear HMGB2 accumulation and inhibits CRT translocation and ferroptosis; exogenous cell-targeted HMGB2 (CT-HMGB2) is three orders of magnitude more potent than oxaliplatin at inducing CRT translocation.\",\n      \"method\": \"XPO1 inhibition (selinexor), nuclear fractionation, confocal microscopy (CRT translocation), ferroptosis assay, exogenous CT-HMGB2 protein treatment, flow cytometry\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — pharmacological inhibition of nuclear export, exogenous protein rescue experiment, direct mechanistic link between HMGB2 secretion and CRT translocation, multiple cell lines and orthogonal readouts\",\n      \"pmids\": [\"39354146\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Spatiotemporal expression of HMGB2 regulates hepatocyte proliferation and cell size during liver regeneration; Hmgb2-/- mice show significantly delayed hepatocyte proliferation with decreased cyclin D1 and cyclin B1 mRNA, and larger hepatocytes after partial hepatectomy, indicating hepatocyte hypertrophy compensates for reduced proliferation.\",\n      \"method\": \"Hmgb2-/- mice, 70% partial hepatectomy model, immunohistochemistry (Ki67, PCNA), flow cytometry, qPCR (cyclin D1/B1), siRNA knockdown in vitro\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with in vivo regeneration model, specific molecular readouts (cyclins), in vitro validation with siRNA\",\n      \"pmids\": [\"35831365\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Loss of HMGB2 in cardiomyocytes causes AKT inactivation and decreased SERCA2a activity; Hmgb2-/- mice show baseline cardiac dysfunction and worsened cardiac dysfunction after TAC (pressure overload), demonstrating HMGB2 has a cardioprotective role by maintaining AKT signaling and calcium pump activity.\",\n      \"method\": \"Hmgb2-/- mice, TAC surgery, echocardiography, western blot (AKT phosphorylation, SERCA2a), cardiac function measurements\",\n      \"journal\": \"Circulation journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout with in vivo cardiac phenotype and molecular mechanism (AKT, SERCA2a), single lab\",\n      \"pmids\": [\"30487376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"HMGB2 overexpression promotes ischemia/reperfusion-induced apoptosis through activating the JNK1/2-NF-κBp65 signaling pathway in AC16 cardiomyocytes; HMGB2 silencing inhibits I/R-induced JNK1/2 and NF-κBp65 activation; JNK1/2 inhibitor (SP600125) and NF-κB inhibitor (PDTC) reverse HMGB2 overexpression-induced injury.\",\n      \"method\": \"HMGB2 overexpression and shRNA knockdown, SP600125/PDTC pharmacological inhibition, western blot (JNK1/2, NF-κBp65, Bax/Bcl-2, caspase-3), CCK-8, flow cytometry, TUNEL\",\n      \"journal\": \"Biomedicine & pharmacotherapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain- and loss-of-function with pathway inhibitor validation, single lab, multiple molecular readouts\",\n      \"pmids\": [\"30119172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Post-translational modifications (PTMs) of HMGB2 are located predominantly in the B-domain and within the linker region (in contrast to HMGB1 where PTMs are in the A-domain and linker), as determined by MALDI mass spectrometry; despite high sequence homology, HMGB1 and HMGB2 have slightly different secondary structures as measured by CD spectroscopy.\",\n      \"method\": \"MALDI mass spectrometry (PTM mapping), UV circular dichroism spectroscopy\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — direct structural and PTM characterization by two methods but limited functional validation of PTM consequences\",\n      \"pmids\": [\"36834988\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"HMGB2 is required for hepatic stellate cell (HSC) activation and liver fibrosis; Hmgb2-/- mice or HMGB2-inhibitor (inflachromene)-treated mice show impaired HSC transdifferentiation (reduced α-SMA) and slowed CCl4-induced fibrosis; AAV8-mediated HMGB2 overexpression enhances fibrosis; RNA-seq in Hmgb2-/- mice identifies top activated genes in integrin signaling, inflammation, cell cycle, and extracellular matrix pathways.\",\n      \"method\": \"Hmgb2-/- mice, AAV8-Hmgb2 overexpression, CCl4 fibrosis model, primary HSC isolation and transdifferentiation assay, small molecule inhibitor (inflachromene), lipo-shHMGB2, RNA-seq\",\n      \"journal\": \"Hepatology communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout and gain-of-function in vivo, primary cell isolation, pharmacological inhibition, RNA-seq pathway analysis, multiple orthogonal approaches\",\n      \"pmids\": [\"37930124\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"HMGB2 promotes myocardial ischemic injury in rats by enhancing reactive oxygen species (ROS) production via RAGE signaling, thereby aggravating cardiomyocyte apoptosis, inflammation, and autophagosome clearance impairment; RAGE knockdown attenuates HMGB2-induced effects; TLR4 is not involved.\",\n      \"method\": \"Intramyocardial HMGB2 protein injection in MI rats, NADPH oxidase inhibitor (apocynin) co-treatment, RAGE knockdown (siRNA), ROS measurement, echocardiography, histopathology, western blot\",\n      \"journal\": \"American journal of physiology. Heart and circulatory physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct protein injection in vivo, receptor knockdown distinguishing RAGE from TLR4, ROS mechanism, single lab\",\n      \"pmids\": [\"28011583\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"HMGB2 knockdown in colorectal cancer cells reduces VSMC-like migration and invasion by stabilizing HMGB2 in the cytoplasm; lnc-CRCMSL physically binds HMGB2 and retains it in the cytoplasm, preventing nuclear entry; nuclear HMGB2 triggers EMT by interacting with OCT4; leptomycin B (nuclear export inhibitor) counteracts lnc-CRCMSL-mediated suppression by accumulating nuclear HMGB2.\",\n      \"method\": \"RNA pull-down assay (lnc-CRCMSL/HMGB2 interaction), subcellular fractionation, immunofluorescence, leptomycin B treatment, co-IP (HMGB2/OCT4), knockdown/overexpression, in vivo tumor model\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct RNA-protein interaction by pull-down, HMGB2/OCT4 co-IP, nuclear export inhibitor experiment, subcellular localization with functional consequence\",\n      \"pmids\": [\"30575817\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"miR-127-5p inhibits granulosa cell (GC) proliferation and impairs DNA damage repair capacity by targeting HMGB2; miR-127-5p upregulation in GCs from premature ovarian insufficiency patients reduces HMGB2 protein; in vivo, miR-127-5p attenuates DNA repair via HMGB2 in mouse ovary.\",\n      \"method\": \"miRNA mimic/inhibitor transfection, luciferase reporter assay (HMGB2 3'UTR), western blot, DNA damage repair assay, orthotopic mouse model, flow cytometry\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct target validation by 3'UTR reporter assay, in vitro and in vivo functional assays, single lab\",\n      \"pmids\": [\"32391592\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"HMG2 mRNA level peaks at G2 phase of the cell cycle in rat fibroblasts; expression of antisense HMG2 RNA in COS-1 cells represses cell cycle progression at G1/S, resulting in decreased cell growth, indicating HMG2 expression is required for cell proliferation.\",\n      \"method\": \"Northern blot (cell cycle staging), antisense RNA expression (cell cycle analysis)\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — antisense loss-of-function with specific cell cycle arrest phenotype, cell cycle expression profiling, single lab\",\n      \"pmids\": [\"7763232\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HMGB2 is a multifunctional chromatin-associated architectural protein that bends and unwinds DNA through its two HMG box domains (box B being the primary DNA recognition/bending domain), activates RNA Pol II transcription by stabilizing the TFIID-TFIIA-promoter complex, and also represses basal transcription until counteracted by TFIIH-associated ATPase activity; it participates in diverse gene-regulatory complexes (with RAG1/2 for V(D)J recombination, Lef-1/β-catenin for Wnt signaling, p53/p73, ER/SRC-1, Oct4/SET, and GFI1B-promoter-associated factors); its nuclear localization is determined by HMG box flanking basic regions with retention requiring the acidic C-terminus; acetylation enhances its nucleosome binding and chromatin-remodeling co-activity; its nuclear depletion upon senescence entry drives CTCF clustering and 3D genome reorganization that primes the SASP, while its preferential localization to SASP gene loci prevents heterochromatin spreading into these regions; extracellular HMGB2 (secreted via XPO1-dependent nuclear export) induces calreticulin translocation for immunogenic cell death and activates RAGE-mediated ROS signaling; loss of HMGB2 in vivo causes defects in spermatogenesis, cartilage homeostasis, erythroid differentiation, muscle regeneration, neural stem cell proliferation, hematopoietic stem cell maintenance, adipogenesis, hepatocyte proliferation, cardiac function (via AKT/SERCA2a), and T cell exhaustion differentiation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"HMGB2 is a sequence-nonspecific architectural chromatin protein that uses its two HMG box domains to bend, unwind, and structurally remodel DNA, thereby acting as a versatile facilitator of nucleoprotein complex assembly and gene regulation [#0, #2, #13]. It bends DNA extremely efficiently — forming circles as small as 66 bp and substituting for prokaryotic HU in invertasome assembly — and reduces DNA linking number by local denaturation of base pairs, with box B serving as the primary DNA-recognition and bending domain (Phe-102 intercalating into the base stack) and box A acting through a flexible hinge mechanism [#0, #1, #2, #13, #14]. Through these activities HMGB2 modulates transcription in opposing directions: in reconstituted RNA Pol II systems it activates transcription by stabilizing the TFIID-TFIIA-promoter complex and slowing TFIIB dissociation, yet also acts as a basal repressor of class II genes that is relieved by an ATP-dependent TFIIH-associated activity [#3, #4]. As an architectural co-factor it is recruited into diverse regulatory complexes — the RAG1/2 recombinase machinery where it enhances binding and bending of recombination signal sequences [#5, #6], Lef-1/\\u03b2-catenin Wnt complexes [#17], the SET complex at the ER [#7], and ER/SRC-1 complexes in tamoxifen-resistant breast cancer [#24] — and it directly occupies and regulates specific promoters including GFI1B, C/EBP\\u03b2, and latexin to control erythroid differentiation, adipogenesis, and hematopoietic stem cell maintenance [#19, #32, #34]. Its activity is tuned by acetylation, which confers nucleosome-core-particle binding and enhances co-remodeling with SWI/SNF and RSC [#18], and its nucleocytoplasmic distribution is governed by an HMG-box-flanking NLS, acidic C-terminal retention, and lncRNA binding, with granzyme A cleavage after Lys65 destroying its DNA functions [#7, #11, #43]. In senescence HMGB2 is depleted from the nucleus, an event sufficient to drive CTCF clustering and 3D genome reorganization while its preferential occupancy of SASP loci shields them from heterochromatin spreading [#26, #28]. Secreted HMGB2, exported via XPO1, signals extracellularly through RAGE-mediated ROS to drive vascular and myocardial injury and induces calreticulin translocation for immunogenic cell death [#29, #36, #42]. Across genetic knockouts, HMGB2 is required for spermatogenesis, cartilage homeostasis, neural stem cell control, muscle regeneration, hepatocyte proliferation, adipogenesis, hematopoietic stem cell maintenance, and exhausted-progenitor T cell differentiation [#9, #16, #23, #27, #31, #34, #37].\",\n  \"teleology\": [\n    {\n      \"year\": 1979,\n      \"claim\": \"Established the foundational biochemical activity of HMGB2 on DNA structure, defining it as a DNA-distorting protein rather than a sequence-specific factor.\",\n      \"evidence\": \"Topological winding number assays and melting absorption measurements with circular DNA\",\n      \"pmids\": [\"628842\", \"226939\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address sequence preference or in vivo relevance\", \"Quantitative unwinding angle measured in vitro only\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Demonstrated HMGB2 bends DNA extremely efficiently and identified box B as sufficient for bending and complex nucleoprotein assembly, framing HMGB2 as an architectural facilitator.\",\n      \"evidence\": \"Ligase-mediated circularization, invertasome assembly, and partial proteolysis domain mapping\",\n      \"pmids\": [\"8339930\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Box A contribution not fully resolved\", \"Physiological nucleoprotein targets not identified\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Refined the division of labor between the HMG boxes, showing box B is the primary DNA-recognition/bending domain with an intercalating residue while box A acts via a flexible hinge.\",\n      \"evidence\": \"Gel retardation, SPR, supercoiling assays with domain mutants, single-molecule optical tweezers, computer modeling\",\n      \"pmids\": [\"9888798\", \"15833996\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cooperative filament binding mode mechanism incompletely defined\", \"In vivo consequences of distinct binding modes unclear\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Linked HMGB2's biochemical DNA activity to transcriptional control, showing it both activates Pol II transcription by stabilizing TFIID-TFIIA and represses basal transcription until relieved by TFIIH ATPase activity.\",\n      \"evidence\": \"Defined reconstituted in vitro Pol II transcription with purified factors, order-of-addition, antibody depletion, nucleotide-analog tests\",\n      \"pmids\": [\"7797075\", \"8007973\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The TFIIH-associated counteracting factor not molecularly identified\", \"Promoter context determining activation vs repression not defined\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Placed HMGB2 in the V(D)J recombination machinery, showing it is incorporated into RAG1/RSS complexes and enhances RAG binding and 23RSS bending.\",\n      \"evidence\": \"Protein-protein interaction, EMSA, circular permutation bending, in vivo recombination assays with recombinant proteins\",\n      \"pmids\": [\"10490593\", \"10390537\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry within the cleavage complex not resolved\", \"Relative roles of HMGB1 vs HMGB2 in vivo not distinguished\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Defined how HMGB2 subcellular localization is controlled, identifying a novel HMG-box-interspaced NLS and an acidic C-terminal nuclear retention requirement.\",\n      \"evidence\": \"Fusion-protein deletion mapping in COS-7 cells and interspecies heterokaryon retention assay\",\n      \"pmids\": [\"9166769\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trans-acting import/retention factors not identified\", \"Regulation of shuttling by signals not addressed\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Revealed a cytoplasmic, ER-associated pool of HMGB2 within the SET complex and identified it as a granzyme A substrate, connecting its DNA activity to cytotoxic cell death.\",\n      \"evidence\": \"Reciprocal co-IP, confocal colocalization, in vitro granzyme A cleavage with functional DNA-binding readouts\",\n      \"pmids\": [\"11909973\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional role of cytoplasmic HMGB2 beyond cleavage substrate unclear\", \"Regulation of nuclear vs cytoplasmic partitioning of the SET complex not defined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Clarified that HMGB2 remains dynamically associated with mitotic chromosomes, correcting prior fixation artifacts and mapping two binding sites to boxes A and B.\",\n      \"evidence\": \"Live-cell imaging of tagged proteins, FRAP, permeabilization controls\",\n      \"pmids\": [\"12925773\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of mitotic chromosome binding not established\", \"Exchange kinetics not linked to a regulatory output\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Established HMGB2 as a partner in multiple transcription-factor complexes governing differentiation, including Lef-1/\\u03b2-catenin Wnt signaling and direct GFI1B promoter regulation for erythroid differentiation, with acetylation enabling nucleosome binding and chromatin co-remodeling.\",\n      \"evidence\": \"Co-IP, ChIP, reporter assays, conditional \\u03b2-catenin knockout, nucleosome mobilization with SWI/SNF and RSC, siRNA differentiation assays\",\n      \"pmids\": [\"19805379\", \"19965638\", \"19522541\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Acetylation effects shown for native protein but site-specific causality limited\", \"Generality of complex recruitment across loci not fully mapped\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Connected HMGB2 to the p53/p73 tumor-suppressor axis, showing it binds p73 and contextually modulates p53/p73-dependent transactivation, and later that it stabilizes p53 by blocking HPV E6-mediated degradation.\",\n      \"evidence\": \"Pull-down, EMSA, luciferase reporters, ubiquitination assay, cell cycle FACS across multiple cell lines\",\n      \"pmids\": [\"11748232\", \"20036050\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-type-dependent opposite effects mechanistically unexplained\", \"p53-stabilization restricted to HPV-positive context\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defined in vivo physiological requirements for HMGB2 through cartilage knockout studies, linking its loss to chondrocyte apoptosis and accelerated osteoarthritis, and showing it suppresses chondrogenic differentiation via Wnt/Runx2.\",\n      \"evidence\": \"Hmgb2-/- mice, histology, in vitro apoptosis and reporter assays, MSC gain/loss-of-function\",\n      \"pmids\": [\"19139395\", \"21890638\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct chromatin targets in chondrocytes not enumerated\", \"Mechanism coupling DNA binding to apoptosis protection unclear\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Established HMGB2 as a master regulator of senescence-associated genome architecture, acting both as a driver of CTCF clustering/3D reorganization and as a boundary factor protecting SASP loci from heterochromatin spreading.\",\n      \"evidence\": \"ChIP-seq for HMGB2 and histone marks, Hi-C, knockdown and rescue across multiple cell types, immunofluorescence\",\n      \"pmids\": [\"27799366\", \"29706538\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which HMGB2 marks SASP boundaries molecularly undefined\", \"Trigger for nuclear depletion at senescence entry unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showed HMGB2 controls myogenic and other tissue regeneration programs through transcriptional regulation of downstream effectors such as IGF2BP2, coupling chromatin function to satellite/progenitor cell behavior.\",\n      \"evidence\": \"siRNA/overexpression, ChIP, IGF2BP2 rescue, in vivo muscle injury model\",\n      \"pmids\": [\"27672022\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect promoter occupancy at IGF2BP2 partially resolved\", \"Generalizability across regenerating tissues not tested in one model\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defined an extracellular signaling role for HMGB2, acting through RAGE (not TLR4) to drive ROS production and tissue injury in vascular and myocardial contexts.\",\n      \"evidence\": \"Hmgb2-/- injury models, perivascular/intramyocardial protein administration, RAGE/TLR4 knockdown, ROS and NADPH oxidase assays\",\n      \"pmids\": [\"28183701\", \"28011583\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Secretion mechanism in these contexts not defined\", \"Downstream RAGE effector pathway partially characterized\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrated that HMGB2 nucleocytoplasmic partitioning is regulated by lncRNAs and XPO1-dependent export, with localization dictating function from EMT (nuclear/OCT4) to immunogenic cell death (secreted/calreticulin).\",\n      \"evidence\": \"RNA pull-down, subcellular fractionation, leptomycin B/selinexor export inhibition, co-IP, CRT translocation and ferroptosis assays, exogenous CT-HMGB2 protein\",\n      \"pmids\": [\"30575817\", \"39354146\", \"25937287\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signals triggering XPO1-dependent secretion not identified\", \"Relationship between lncRNA sequestration and active export not integrated\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Revealed an epitranscriptomic layer controlling HMGB2 abundance, where NAT10-mediated ac4C modification of HMGB2 mRNA enhances its translation via eEF2 binding to promote tumor proliferation.\",\n      \"evidence\": \"acRIP-seq, ribosome profiling, RNA pull-back/MS, site-specific mutation, in vitro and in vivo HCC models\",\n      \"pmids\": [\"39030964\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ac4C regulation operates outside HCC unknown\", \"Quantitative contribution of translation control vs transcription not separated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the same architectural protein achieves opposing transcriptional outcomes and partitions among nuclear chromatin, cytoplasmic complexes, and secreted signaling pools in a context-specific manner remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No unifying model linking DNA-bending activity to selective gene-regulatory outcomes\", \"Upstream signals dictating subcellular partitioning and secretion not defined\", \"Functional distinction between HMGB1 and HMGB2 at shared loci incompletely mapped\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 1, 2, 13, 14, 19, 34]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [25]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [3, 4, 17, 19, 24, 32, 34]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 13, 26, 28]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [29, 42]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [11, 26, 28, 43]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [7, 43]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [29, 36, 42]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [3, 4, 17, 19, 24, 34]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [18, 26, 28]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [9, 16, 23, 27, 34]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [26, 28]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [5, 6, 31, 36]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [12, 16, 36, 39]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [17, 29, 42]}\n    ],\n    \"complexes\": [\"SET complex\", \"RAG1/2-RSS recombinase complex\", \"HMGB2/SRC-1/ER complex\", \"TFIID-TFIIA preinitiation complex\"],\n    \"partners\": [\"RAG1\", \"SET\", \"TP73\", \"LEF1\", \"SRC-1\", \"OCT4\", \"C/EBPB\", \"GFI1B\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}